ethinyl estradiol has been researched along with cyproterone acetate in 380 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 105 (27.63) | 18.7374 |
| 1990's | 78 (20.53) | 18.2507 |
| 2000's | 107 (28.16) | 29.6817 |
| 2010's | 80 (21.05) | 24.3611 |
| 2020's | 10 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ramsay, ID; Rushton, DH | 2 |
| Brändle, E; Gottwald, E; Melzer, H; Sieberth, HG | 1 |
| Arranz, B; Bonnin, MR; Gómez, JM; Montaña, E; Navarro, MA; Soler, J | 1 |
| Ali, A; Bassaw, B; Maharaj, R; Roopnarinesingh, S | 1 |
| Laatikainen, T; Seppälä, M; Stenman, UH; Suikkari, AM; Tiitinen, A | 1 |
| Cunningham, SK; McKenna, TJ | 1 |
| Burrows, D; Eedy, DJ | 1 |
| Brun, JG; Seroka, J | 1 |
| Giagulli, VA; Giorgino, R; Vermeulen, A | 1 |
| Arcaini, L; Bianchi, S; Brioschi, D; Di Nola, G; Fedele, L; Marchini, M | 1 |
| Gruner, S; Kaiser, E | 1 |
| Barth, JH; Cherry, CA; Dawber, RP; Wojnarowska, F | 1 |
| Wishart, JM | 1 |
| Eden, JA | 1 |
| Poláchová, I | 1 |
| Audebert, A; Emperaire, JC; Gauthier, A; Hallonet, P; Hedon, B; Lopes, P; Quereux, C; Roulier, R | 1 |
| Beaucaire, G; Beuscart, C; Brion, M; Leroy, O; Senneville, E; Tillie, I; Visticot, F | 1 |
| Blankenstein, MA; Haspels, AA; Kloosterboer, HJ; Thijssen, JH; van der Vange, N | 1 |
| Cathelineau, G; Fiet, J; Hardy, N; Martineau, I; Vexiau, P; Vexiau-Robert, D; Villette, JM | 1 |
| Gaspard, UJ; Humblet, DM; Jaminet, CB; Jandrain, BJ; Lefebvre, PJ; Scheen, AJ | 2 |
| Dericks-Tan, JS; Taubert, HD | 1 |
| Jung-Hoffman, C; Kuhl, H | 1 |
| Falsetti, L; Galbignani, E | 1 |
| Davignon, J; Farquhar, D; Fugère, P; Lussier-Cacan, S; Percival-Smith, RK | 1 |
| Egyedi, K; Kása, M; Raffai, S; Török, L | 1 |
| Balint-Perić, L; Prelević, GM; Trpković, D; Würzburger, MI | 1 |
| Koh, SC; Ratnam, SS; Tsakok, FH | 1 |
| Borradori, L; Marie, O; Morel, P; Rybojad, M; Späth, P; Vexiau, P | 1 |
| Balint-Perić, L; Prelević, GM; Puzigaća, Z; Würzburger, MI | 1 |
| Arcaini, L; Baglioni, A; Bianchi, S; Fedele, L; Vercellini, P | 1 |
| Bertolotto, A; Fioretti, P; Fruzzetti, F; Giampietro, O; Melis, G; Miccoli, R; Navalesi, R; Orlandi, MC; Ricci, C | 1 |
| Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N | 1 |
| Asscheman, H; Gooren, L; Lips, P; Netelenbos, JC; Uitewaal, P | 1 |
| Peereboom-Wynia, JD; Stolz, E; van der Willigen, AH; van Joost, T | 1 |
| Ernst, E; Matrai, A; Schmölzl, C; Schramm, W | 1 |
| Croxson, MS; France, J; Holdaway, IM; Ibbertson, HK; Knox, B; Sheehan, A | 1 |
| Bovicelli, L; Fabbri, R; Flamigni, C; Orsini, LF; Paradisi, R; Porcu, E; Saviotti, E; Venturoli, S | 1 |
| Brummitt, L; Burke, B; Cunliffe, WJ; Greenwood, R | 2 |
| Larsen, J; Nielsen, DR; Pedersen, IM; Starup, J | 2 |
| Hammerstein, J | 1 |
| Bye, P | 2 |
| de Vries, CP; Gooren, LJ; van der Veen, EA | 1 |
| Cunliffe, WJ | 1 |
| Rajka, G | 1 |
| Godsland, IF; Jacobs, HS; Seed, M; Wynn, V | 2 |
| Ashton, RE; Dowd, PM; Griffiths, WA; Jacobs, HS; Miller, JA; O'Brien, TJ; Wojnarowska, FT | 1 |
| Jacobs, HS; Miller, JA | 1 |
| Meyrick, RL | 1 |
| Fåhraeus, L; Larsson-Cohn, U; von Schenck, H; Wallentin, L | 1 |
| Aydinlik, S; Lachnit-Fixson, U; Lehnert, J | 1 |
| Dawber, RP; Gales, MA; Moore, RA; Mortimer, PS | 1 |
| Ebling, FJ; Randall, VA; Sawers, RS | 1 |
| Guber, A; Poran, J; Schindler, D; Shachor, Y | 1 |
| Korchevaia, TA; Kravchenko, LIa; Rubina, VV | 1 |
| Belisle, S; Love, EJ | 1 |
| Cunliffe, WJ; Downing, DT; Greenwood, R; Stewart, ME; Strauss, JS | 1 |
| Kaiser, E | 1 |
| Cabero-Roura, A; Calaf-Alsina, J; Esteban-Altirriba, J; Lenti-Paoli, O; Mora-Brugues, J; Rodriguez-Espinosa, J | 1 |
| Carlborg, L | 1 |
| Crona, N; Enk, L; Lindberg, UB; Samsioe, G; Silfverstolpe, G | 1 |
| Gruner, HS; Kaiser, E | 1 |
| Godsland, I; Parr, JH; Seed, M; Wynn, V | 1 |
| Bouman, FG; de Voogt, HJ; Geldof, AA; Gooren, LJ; Rao, BR | 1 |
| Edwards, CR; Ibraham, I; Jones, DB | 1 |
| Colver, GB; Dawber, RP; Mortimer, PS | 1 |
| Montanari, L; Pelfini, C; Vignini, M | 1 |
| Biffignandi, P; Molinatti, GM | 1 |
| De Crée, C; Lewin, R; Ostyn, M | 1 |
| Mehrl, J | 1 |
| Rubens, R; Vermeulen, A | 1 |
| Abraham, RR; Parr, JH; Seed, M; Short, F; Wynn, V | 1 |
| Abrahamian-Michalakis, A; Adamopoulos, DA; Georgiacodis, F; Kampyli, S; Kapolla, N | 1 |
| Arzt, W; Mursch-Edlmayr, G; Tews, G | 1 |
| Asscheman, H; Assies, J; de Slegte, R; Gooren, LJ; Smits, JP | 1 |
| Huber, J; Schmidt, JB; Spona, J | 1 |
| Alund, G; Varenhorst, E | 1 |
| Gooren, LJ; Harmsen-Louman, W; van Kessel, H | 1 |
| Baumgarten, S; Hammerstein, J; Moltz, L; Römmler, A; Schwartz, U | 1 |
| Butturini, U; Gerra, G; Rastelli, G; Valenti, G; Vescovi, PP | 1 |
| Abbate, R; Bruni, V; Bucciantini, S; Costanzo, G; Costanzo, M; Pinto, S; Rosati, D; Verni, A | 1 |
| Baglioni, A; Cavalli, G; Fedele, L; Marchini, M; Taccagni, GL | 1 |
| Djøseland, O; Lunde, O | 1 |
| Kuhl, H; Mehlis, W; Sandow, J; Taubert, HD; Weber, W | 1 |
| Antonelli, S; Barletta, C; Buzzetti, R; Dino, N; Giovannini, C; Raccamarich, I; Tarasco, A | 1 |
| Lyons, F; Marsden, JR; Shuster, S | 1 |
| Marsden, J; Shuster, S | 1 |
| Habenicht, UF; Neumann, F | 1 |
| Hansted, B; Reymann, F | 2 |
| Baxendale, PM; Jacobs, HS; James, VH | 2 |
| Carlström, K; Eneroth, P; Lunell, NO; Patek, E; Wager, J; Zador, G | 1 |
| Hammond, GL; Lähteenmäki, P; Lähteenmäki, PL; Luukkainen, T | 1 |
| Lu, YC; Pai, IF; Wu, YC | 1 |
| Mugglestone, CJ; Rhodes, EL | 1 |
| Dammé, J; Schulte-Hermann, R; Schuppler, J | 1 |
| Eggert, J; Zachariae, H | 1 |
| Acosta, H; Piquero Martín, J | 1 |
| Döring, HF; Ilgner, M | 1 |
| Hammerstein, J; Moltz, L; Schwartz, U | 2 |
| Allen, JK; Fraser, IS; McCarron, G; Shearman, RP | 1 |
| Croxson, MS; Evans, MC; France, J; Holdaway, IM; Ibbertson, HK; Sheehan, A; Wilson, T | 1 |
| Corsello, SM; De Rosa, G; Liberale, I; Menini, E; Moneta, E; Pasargiklian, E | 1 |
| Garner, PR; Poznanski, N | 1 |
| Rubens, R | 1 |
| Bercovici, JP; Grulier, A | 1 |
| James, KC; Mortimer, CH; Rushton, H | 1 |
| Gerny, H | 1 |
| Morer, F; Ordoñez, J; Rodriguez, J; Salva, P | 1 |
| Appelt, H; Strauss, B | 1 |
| D'Ambrogio, G; Facchini, V; Genazzani, AR; Inaudi, P; Massafra, C | 1 |
| Chapman, MG; Dewhurst, CJ; Jeffcoate, SL | 1 |
| Carlström, K; Larsson, L; Tiselius, HG; Varenhorst, E | 1 |
| De Rooy, HA; Frölich, M; Vader, HL; Walma, ST | 1 |
| Aakvaag, A; Frey, H | 1 |
| Arevalo, A; Michelotti, M; Montero, ED | 1 |
| Apró, G; Sas, M | 1 |
| Varenhorst, E; Wallentin, L | 1 |
| Gordon, W; Jones, KR; Katz, M; Keyzer, C | 1 |
| Lehucher-Ceyrac, D; Saurat, JH; Weber-Buisset, MJ | 1 |
| Ylöstalo, P | 1 |
| Cramers, M; Zachariae, H | 1 |
| Cyganek, A; Grzechocińska, B; Marianowski, L | 1 |
| Kuhnz, W; Löfberg, B | 1 |
| van den Ende, A; van Wayjen, RG | 1 |
| Gooren, LJ; Polderman, KH; van der Veen, EA | 1 |
| Bowman, SJ; Gendi, NS; Mowat, AG | 1 |
| Bennink, HJ; Dieben, TO; Theeuwes, A; Vromans, L | 1 |
| Falsetti, L; Pasinetti, E | 1 |
| Aravantinos, D; Creatsas, G; Deligeoroglou, E; Hassan, E; Tolis, G | 1 |
| Asscheman, H; Bakker, A; Gooren, LJ; Heine, RJ; Polderman, KH | 1 |
| Dal Prato, L; Fabbri, R; Flamigni, C; Paradisi, R; Porcu, E; Venturoli, S | 1 |
| Jütting, G; Kuhnz, W; Staks, T | 1 |
| Gerhard, I; Matthes, J; Runnebaum, B | 1 |
| Balint-Perić, LA; Prelević, GM; Puzigaća, Z | 1 |
| Elstein, ME; Golland, IM | 1 |
| Dekker, GA; Gooren, LJ; Polderman, KH; Stehouwer, CD; van Kamp, GJ; Verheugt, FW | 1 |
| Aglianò, A; Cianci, A; Ciotta, L; Giuffrida, G; Marletta, E; Palumbo, G | 1 |
| Gaspard, UJ; Hendrick, JC; Nervo, P; van den Brûle, FA | 1 |
| Durmuşoğlu, F; Erenus, M; Gürbüz, O; Pekin, S; Yücelten, D | 1 |
| Erdmann, D; Schindler, AE; Schindler, EM | 1 |
| Aydinlik, S; Braunschweig, T; Gurr, S; Kaufmann, J; Klinger, G; Schelhorn, P; Siegert, C; Wendler, J | 1 |
| Hardy, J; Noiseux, D; Robert, F; Serri, O | 1 |
| Crosignani, PG; Falsetti, L; Maggioni, P; Motta, T; Testa, G; Vegetti, W | 1 |
| Avivi, I; Blumenfeld, Z; Gideoni, O; Linn, S; Pollack, S | 1 |
| Acién, P; Gutierrez, M; Mauri, M | 1 |
| Carmina, E; Lobo, RA | 2 |
| Alberti, A; Schepis, C; Siregusa, M | 1 |
| Dramusic, V; Goh, VH; Rajan, U; Ratnam, SS; Wong, YC | 1 |
| Keleştimur, F; Sahin, Y | 2 |
| Asscheman, H; Elbers, JM; Giltay, EJ; Gooren, LJ; Hoogeveen, EK; Stehouwer, CD | 1 |
| Gruber, DM; Heinze, G; Huber, JC; Joura, EA; Kokoschka, EM; Sator, MO | 1 |
| Adebayo, GI; Bonnar, J; Devitt, M; Feely, J; Norris, L | 1 |
| Bagnoli, A; Colombo, FM; Flamigni, C; Iadarola, I; Macrelli, S; Mancini, F; Ravaioli, B; Venturoli, S; Vianello, F | 1 |
| Bayram, F; Keleştimur, F; Müderris, I; Sahin, Y | 1 |
| Teichmann, AT | 1 |
| Castelo-Branco, C; Martínez de Osaba, MJ; Pons, F; Vanrell, JA | 1 |
| Dahlgren, E; Holm, G; Janson, PO; Krotkiewski, M; Landin, K | 2 |
| Asscheman, H; Elbers, JM; Gooren, LJ; Seidell, JC | 1 |
| Bagnoli, A; Colombo, FM; Flamigni, C; Macrelli, S; Marescalchi, O; Paradisi, R; Ravaioli, B; Venturoli, S | 1 |
| Cohen-Kettenis, PT; Gooren, LJ; Megens, J; Slabbekoorn, D; van Goozen, SH | 1 |
| Gjønnaess, H | 1 |
| Bloemena, E; Hage, JJ; Kanhai, RC; Karim, RB; van Diest, PJ | 1 |
| Albring, M; Brill, K; Gollnick, H | 1 |
| Frass, M; Gmeiner, B; Hofbauer, R; Kapiotis, S; Kaye, AD; Kos, T; Salfinger, H; Salzer, H; Wagner, O | 1 |
| Bloemena, E; Hage, JJ; Kanhai, RC; Mulder, JW; van Diest, PJ | 1 |
| Asscheman, H; Hage, JJ; Kanhai, RC; Mulder, JW | 1 |
| Diamandis, EP; Giltay, EJ; Gooren, L; Magklara, A; Obiezu, CV; Scorilas, A; Yu, H | 1 |
| Kokaly, W; McKenna, TJ | 1 |
| Cicinelli, E; D'Addario, V; De Pergola, G; De Salvia, MA; Schonauer, LM; Tartagni, M | 1 |
| Drexhage, HA; Fonk, JC; Giltay, EJ; Gooren, LJ; Schalkwijk, C; von Blomberg, BM | 1 |
| Lhullier, F; Lisboa, KO; Mattiello, S; Spritzer, PM | 1 |
| Emeis, JJ; Giltay, EJ; Gooren, LJ; Kooistra, T; Stehouwer, CD | 1 |
| Creatsas, G; Koliopoulos, C; Mastorakos, G | 2 |
| Brun, JF; El Bouhmadi, A; Laffargue, F; Raspal, N | 1 |
| Regidor, M; Regidor, PA; Schindler, EM; Speer, K | 1 |
| Koivunen, RM; Martikainen, HK; Morin-Papunen, LC; Ruokonen, A; Tapanainen, JS; Vauhkonen, I | 1 |
| Kleinstein, J; Muenstermann, U | 1 |
| Falsetti, L; Gambera, A; Tisi, G | 1 |
| Armstrong, VL; Atkinson, AB; Bell, PM; Ennis, CN; Sheridan, B; Traub, AI; Wiggam, MI | 1 |
| Caruso, A; De Leo, V; Fulghesu, AM; la Marca, A; Morgante, G; Pasqui, L; Talluri, B; Torricelli, M | 1 |
| Gogate, JG; Shringi, MS; Vaidya, AB; Vaidya, RA | 1 |
| Dilber, S; Keleştimur, F; Sahin, Y | 1 |
| Degreef, H; Tan, JK | 1 |
| Belaish-Allart, J; Cornier, E; el Amrani, R; Henry-Suchet, J; Loysel, T; Mayenga, JM; Sarjdine, K | 1 |
| Belaisch-Allart, J; Cornier, E; el Amrani, R; Henry-Suchet, J; Loysel, T; Mayenga, JM; Sarjdine, K | 1 |
| Broekmeulen, CJ; de Gezelle, H; Vartiainen, M | 1 |
| Kelestimur, F | 1 |
| Borelli, C | 1 |
| Boudou, P; Chaspoux, C; Fiet, J; Hardy, N; Jouanique, C; Reygagne, P; Vexiau, P | 1 |
| Akdogan, M; Aydog, G; Kacar, S; Koşar, Y; Oguz, P; Parlak, E; Sasmaz, N | 1 |
| Durmusoglu, F; Elter, K; Imir, G | 1 |
| Herer, P; Luboshitzky, R; Shen-Orr, Z | 2 |
| Acosta, E; Blanes-espi, A; Ferrer-barriendos, J; Millet-part, A; Siqueira, L | 1 |
| Wynn, V | 1 |
| Kasa, M; Torok, L | 1 |
| Henrion, R; Laveissiere, MN | 1 |
| Koivunen, R; Martikainen, H; Morin-Papunen, L; Ruokonen, A; Tapanainen, JS; Vauhkonen, I | 1 |
| Başogul, O; Inal, M; Ispahi, C; Karanfil, C; Onoglu, A; Taner, C; Tinar, S | 1 |
| Wooltorton, E | 1 |
| de Vries, CS; Farmer, RD; Seaman, HE | 3 |
| Arnold, G; Dreier, JP; Einhäupl, KM; Petzold, GC | 1 |
| Ford, AR; Lexchin, J; Lippman, A; Mintzes, B | 1 |
| Rowe, TC | 1 |
| Nicholls, J | 1 |
| Jemec, GB; Larsen, TH | 1 |
| Koyuncu, FM; Kuscu, NK; Onur, E; Var, A | 1 |
| Lidegaard, Ø | 1 |
| Kirim, S; Sert, M; Tetiker, T | 1 |
| Cagnacci, A; Melis, GB; Orrù, M; Paoletti, AM; Pilloni, M; Renzi, A; Volpe, A | 1 |
| Brzezińska-Wcisło, L | 1 |
| Fleming, R; Harborne, L; Lyall, H; Norman, J; Sattar, N | 1 |
| Hedberg, P; Morin-Papunen, L; Puukka, M; Rautio, K; Ruokonen, A; Tapanainen, JS | 1 |
| le Roux, PA; Van der Spuy, ZM | 1 |
| Harma, M; Kilic, F; Nazligul, Y; Sabuncu, T | 1 |
| Spitzer, WO | 2 |
| Gooren, LJ; Magdeleyns, EJ; Rosing, J; Tans, G; Thomassen, MC; Toorians, AW; Zweegman, S | 1 |
| Herer, P; Luboshitzky, R; Nave, R; Shen-Orr, Z | 1 |
| Ardito, G; Corsello, S; Garcea, N; Garcea, R; Lemmo, G; Palladino, T; Tarquini, E | 1 |
| Meltzer, A | 1 |
| Chen, CY; Chen, PH; Hsieh, BC; Huang, LW; Huang, SC; Hwang, JL; Lin, YH; Seow, KM; Tsai, YL; Tzeng, CR; Wu, GJ | 1 |
| Pini, M | 1 |
| Mitkov, M; Pekhlivanov, B; Terzieva, D | 1 |
| Beigi, A; Sobhi, A; Zarrinkoub, F | 1 |
| Giltay, EJ; Gooren, LJ; Katan, MB; Toorians, AW; Zock, PL | 1 |
| Beasley, R; Henderson, M; Heuser, P; Hopkins, R; Metcalfe, S; Tonga, K; Weatherall, M | 1 |
| Mitkov, M; Pehlivanov, B; Terzieva, D | 1 |
| Arteaga, E; Cárdenas, I; Hormaza, P; Oestreicher, E; Villaseca, P | 1 |
| Morin-Papunen, LC; Rautio, K; Ruokonen, A; Tapanainen, JS | 1 |
| Al-Inany, H | 2 |
| Buyukberber, NM; Gulsen, MT; Kadayifci, A; Karaca, M | 1 |
| Beguin, Y; Feyen, E; Gooren, L; Kaufman, JM; Rubens, R; T'Sjoen, GG | 1 |
| Amanlou, M; Farsam, H; Ghadiri, R; Jalalizadeh, H; Souri, E | 1 |
| Déchêne, F; Dodin, S; Forest, JC; Lemay, A; Turcot, L | 1 |
| Chen, LS; Zhou, JT | 1 |
| Inal, MM; Taner, CE; Yildirim, Y | 1 |
| Cagnacci, A; Paoletti, AM; Renzi, A; Tirelli, A; Volpe, A | 1 |
| Green, R; Hines, M; Miles, C | 1 |
| Foltyn, W; Kos-Kudła, B; Kudła, M; Mazur, B; Małecka-Mikosz, O; Ostrowska, Z | 1 |
| Dvorakova, K; Hill, M; Starka, L; Vrbikova, J | 1 |
| Kubán, V; Matejícek, D | 1 |
| Charitidou, C; Farmakiotis, D; Hatzistilianou, M; Karamanis, N; Katsikis, I; Panidis, D; Pegiou, T; Pidonia, I; Zournatzi, V | 1 |
| Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Lasunción, MA; Luque-Ramírez, M; Martínez-Bermejo, E | 1 |
| Atanasova, I; Genchev, G; Kamenov, Z; Khristov, V; Kolarov, G; Milcheva, B; Orbetsova, M; Shigarminova, R; Zakharieva, S | 1 |
| Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Luque-Ramírez, M; San Millán, JL; Sanchón, R | 1 |
| Demirci, F; Gul, OB; Ozdemir, I; Somunkiran, A; Yucel, O | 1 |
| Tan, JK | 1 |
| Galarza, M; Gazzeri, G; Gazzeri, R | 1 |
| Franks, S; Glasier, A; Layton, A | 1 |
| Dan, M; Nitzan, Z | 1 |
| Baser, I; Dede, M; Erbil, MK; Kenar, L; Oktenli, C; Ozgurtas, T; Sanisoglu, SY; Tapan, S; Yenen, MC; Yesilova, Z | 1 |
| Yildiz, BO | 1 |
| Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Uriol Rivera, MG | 1 |
| Aral, Y; Bavbek, N; Culha, C; Demirbas, B; Güler, S; Karakurt, F; Sahin, I; Serter, R | 1 |
| Bunck, MC; Diamant, M; Giltay, EJ; Gooren, LJ; Teerlink, T; Zitman, FG | 1 |
| Jiang, M; Ma, F; Qi, J; Qiao, L; Wang, L; Xie, S; Xu, K; Yue, H; Zhang, W; Zhou, X | 1 |
| Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Mendieta-Azcona, C | 1 |
| Liao, H; Luo, WY; Sun, Y; Wang, CF; Zhang, D | 1 |
| Cao, Y; Jiang, Y; Wu, J; Zhu, Y | 1 |
| Akcay, A; Bavbek, N; Gumus, II; Karakurt, F; Kargili, A; Koca, C; Kosar, A; Ozbek, M; Selcoki, Y | 1 |
| Jing, Z; Liang-Zhi, X; Tai-Xiang, W; Ying, T; Yu-Jian, J | 1 |
| Hutchison, SK; McGrath, BP; Meyer, C; Moran, LJ; Teede, HJ; Zoungas, S | 1 |
| del Rey Sánchez, JM; Escobar-Morreale, HF; Luque-Ramírez, M; Matíes, M; Mendieta-Azcona, C | 1 |
| Gräser, T; Palombo-Kinne, E; Schellschmidt, I; Schumacher, U | 1 |
| Bunck, MC; Diamant, M; Giltay, EJ; Gooren, LJ; Teerlink, T | 1 |
| Alacacioglu, A; Kebapcilar, AG; Kebapcilar, L; Sari, I; Taner, CE | 1 |
| Gaillard, RC; Gomez, F; Karrer-Voegeli, S; Meuwly, JY; Rey, F; Reymond, MJ | 1 |
| Cabral, CA; Cardoso, LE; Sampaio, FJ; Zamboni, MJ | 1 |
| Bilgir, F; Bilgir, O; Bozkaya, G; Kebapcilar, A; Kebapcilar, L; Sari, I; Taner, C; Yildiz, Y; Yuksel, A | 1 |
| Alacacioglu, A; Bilgir, O; Kebapcilar, AG; Kebapcilar, L; Kozaci, DL; Sari, I; Taner, CE; Yildiz, Y; Yuksel, A | 1 |
| He, JC; Peng, LB; Xu, P | 1 |
| Chen, HF; Chen, MJ; Chen, SU; Ho, HN; Kuo, JJ; Yang, WS; Yang, YS | 1 |
| Goulis, DG; Makedos, A; Panidis, D; Papanikolaou, A | 1 |
| Bilgir, O; Bozkaya, G; Kebapcilar, AG; Kebapcilar, L; Sari, I; Taner, CE; Yildiz, Y | 1 |
| Abdolmaleki, P; Esmaeili, EA; Sohrabi, MR | 1 |
| Ankley, GT; Cavallin, JE; Durhan, EJ; Jensen, KM; Kahl, MD; Makynen, EA; Martinović, D; Mueller, ND; Villeneuve, DL; Wehmas, LC | 1 |
| Decavalas, G; Diamanti-Kandarakis, E; Georgopoulos, NA; Katsikis, I; Panidis, D; Piouka, A; Saltamavros, AD | 1 |
| Kasperska-Zając, A; Zamlynski, J | 1 |
| Gul, S; Kelekci, KH; Kelekci, S; Yengel, I; Yilmaz, B | 1 |
| Asscheman, H; de Ronde, WP; Giltay, EJ; Gooren, LJ; Megens, JA; van Trotsenburg, MA | 1 |
| Bechlioulis, A; Kalantaridou, SN; Katsouras, CS; Kazakos, N; Kravariti, M; Michalis, LK; Naka, KK; Tsatsoulis, A | 1 |
| Biringer, K; Biringerová, Z; Svecová, I; Visnovský, J | 1 |
| Aksoy, ON; Cakir, O; Colak, N; Nazli, Y | 1 |
| Adonakis, G; Armeni, AK; Decavalas, G; Georgopoulos, NA; Karela, A; Markantes, G; Saltamavros, AD; Vervita, V | 1 |
| de Zegher, F; Diaz, M; Ibáñez, L; Lopez-Bermejo, A; Salvador, C; Sánchez-Infantes, D; Sebastiani, G | 1 |
| Gui, SQ; Kuek, S; Wang, WJ | 1 |
| Demirlenk, S; Karabulut, A; Sevket, O | 1 |
| Tandy, RM | 1 |
| Gai, L; Gai, P; Jia, Y; Liu, Y; Shi, H; Wang, S; Yu, X; Zhang, M | 1 |
| Chacón, MR; de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Maymó-Masip, E; Salvador, C; Vendrell, J | 1 |
| Halilova, N | 1 |
| Collier, R | 1 |
| Cebollada-Gracia, AD; Esteban-Jiménez, O; Martínez-Raposo Piedrafita, MC; Velázquez-Lupiáñez, L | 1 |
| de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Marcos, MV; Sebastiani, G | 1 |
| Revuz, J | 2 |
| Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P | 1 |
| Açmaz, G; Boztosun, A; Müderris, II; Ozturk, A | 1 |
| Dixit, S; Fischer, G; Olsson, A | 1 |
| Akdeniz, D; Carlioglu, A; Gumus, II; Karakurt, F; Kaygusuz, I; Uz, B | 1 |
| Arie, S | 1 |
| Jeerakathil, T; Kromm, J | 1 |
| Chan, SS; Chung, JP; Chung, TK; Yiu, AK | 1 |
| Atabekoğlu, CS; Ateş, C; Berker, B; Cetinkaya, SE; Kahraman, K; Ozmen, B; Sönmezer, M; Sükür, YE; Taşkın, S; Tolunay, HE | 1 |
| Armutcu, F; Carlioglu, A; Gumus, II; Karakurt, F; Kasapoglu, B; Kaygusuz, I; Keskin, EA; Koca, C; Uysal, A; Uysal, S | 1 |
| Kant, AC; van Hunsel, FP; van Puijenbroek, EP | 1 |
| Rosendaal, FR | 1 |
| Kant, A; van Hunsel, F; van Puijenbroek, E | 1 |
| Jongwutiwes, T; Leelaphiwat, S; Lertvikool, S; Rattanasiri, S; Sukprasert, M; Tabcharoen, C; Weerakiet, S | 1 |
| Aksoy, A; Carlioglu, A; Gozukara, I; Kabil Kucur, S; Kamalak, Z; Keskin, H; Uludag, EU | 1 |
| Brian, J; Green, C; Jobling, S; Kanda, R; Scholze, M; Williams, R | 1 |
| Cahill, DJ; O'Brien, K | 1 |
| Jin, CL; Wei, LX; Wu, ZC; Zhao, JP | 1 |
| Carter, B; Fedorowicz, Z; Pandis, N; van Zuuren, EJ | 1 |
| Jin, J; Mueck, AO; Ruan, X; Wu, H | 1 |
| Chen, A; Du, J; Du, Y; Liao, YC; Lin, XF; Wang, Y; Wu, C; Wu, RR; Ye, Y; Zhang, XB | 1 |
| Aritürk, N; Eski Yücel, O; Gül, A; Güngor, I; Turgut, M | 1 |
| Feng, W; Jia, YY; Shi, HR; Zhang, DY | 1 |
| de Zegher, F; Díaz, M; Gallego-Escuredo, JM; Ibáñez, L; Villarroya, F | 1 |
| Burton, T; Chua, SL; Desai, N; Garner, SE; Hood, K; Ingram, JR; Kai, AC; Kerdel, F; Ormerod, AD; Piguet, V; Woo, PN | 1 |
| Mao, XG; Tu, AS; Zhong, Y | 1 |
| Czilli, T; Knezevic, S; Peters, C; Tan, J | 1 |
| Lim, CE; Wu, T; Xu, L; Zhang, J; Zhou, K | 1 |
| Asiimwe, A; Cea Soriano, L; García Rodriguez, LA | 1 |
| Bain, P; Fent, K; Riva, F; Siegenthaler, PF | 1 |
| Defreyne, J; T'Sjoen, G | 1 |
| Fung, R; Lega, I | 1 |
| Cui, N; Feng, X; Hao, G; Wang, L; Xu, Y; Zhang, J; Zhao, Z | 1 |
| Cassano, N; Cricelli, C; Cricelli, I; Lapi, F; Simonetti, M; Vena, GA | 1 |
| Bitzer, J; Lopes da Silva Filho, A; Römer, T | 1 |
| Aguilar, A; Kubba, A; Mueck, AO; Ruan, X | 1 |
| Mueck, AO | 1 |
| Asiimwe, A; Bezemer, ID; Herings, RMC; Penning-van Beest, FJA; Smits, E | 1 |
| Cagnacci, A; Cascinu, S; Cortesi, L; Facchinetti, F; Grandi, G; Marcheselli, L; Pavesi, S; Toss, A | 1 |
| Gu, M; Mueck, AO; Ruan, X; Song, J; Wang, H; Wang, L | 2 |
| Cao, Y; Liu, Z; Zhang, L; Zhao, D | 1 |
| Cai, G; Du, J; Li, X; Li, Y; Mueck, AO; Ruan, X; Wang, H; Wang, L; Zhao, Y | 1 |
| Biancardi, MF; Campos, MS; Castro, CH; Falleiros-Júnior, LR; Marques, MR; Pinto, EG; Santos, FCA; Taboga, SR | 1 |
| Gismondi, E | 1 |
| Mohanty, J; Nagy, A; Sahu, A; Tripathy, P | 1 |
| Shi, Y; Tang, L; Ye, J; Zhu, X | 1 |
| Cao, Y; Chen, H; Liu, Z; Yu, X; Zhang, L; Zhao, D; Zhou, X | 1 |
| Chen, H; Cheng, NCL; Lim, CED; Ng, RWC; Zhang, GS | 1 |
| de Jesus, VO; Ferreira, VS; Lucca, BG | 1 |
| Asiimwe, A; Bezemer, ID; Cea Soriano, L; García Rodríguez, LA; Herings, RMC; Lapi, F; Penning-van Beest, FJA; Simonetti, M; Smits, E | 1 |
| Huo, P; Jiang, Z; Le, J; Lei, X; Tang, Q; Tu, H; Yao, J; Zhang, R; Zhang, S | 1 |
| Deng, Y; Ma, RL; Ma, X; Sun, AJ; Wang, YF; Xue, W; Zhu, SY | 1 |
| Hu, H; Li, F; Li, W; Liu, J; Ma, Z; Zou, G | 1 |
| Abdel-Maboud, M; Abdelraoof, MI; Alshandidy, M; Eid, M; Hasabo, EA; Menshawy, A; Menshawy, E; Outani, O | 1 |
| Álvarez-Blasco, F; de Lope Quiñones, S; Escobar-Morreale, HF; Fernández-Durán, E; Insenser, M; Luque-Ramírez, M; Martínez-García, MÁ; Nattero-Chávez, L; Ortiz-Flores, AE; Quintero-Tobar, A | 1 |
| Chen, X; Feng, Y; Li, X; Liu, Y; Wang, Y; Yao, D; Zhang, F | 1 |
| Brodowska, A; Cymbaluk-Płoska, A; Kozłowski, M; Lorenz, A; Malanowska, E; Niedzielska, M; Przepiera, A; Sowińska-Przepiera, E | 1 |
| Alesi, S; Forslund, M; Melin, J; Mousa, A; Pena, A; Piltonen, T; Romualdi, D; Tay, CT; Teede, H; Witchel, S | 1 |
22 review(s) available for ethinyl estradiol and cyproterone acetate
| Article | Year |
|---|---|
Dianette for women with acne.
Topics: Acne Vulgaris; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1990 |
Acne vulgaris. The past. The present and the future.
Topics: Acne Vulgaris; Androgen Antagonists; Androgens; Benzoyl Peroxide; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Erythromycin; Ethinyl Estradiol; Female; Humans; Isotretinoin; Male; Propionibacterium acnes; Sebum; Tetracycline; Tretinoin | 1985 |
Treatment of hirsutism and acne with cyproterone acetate.
Topics: Acne Vulgaris; Androgen Antagonists; Carbohydrate Metabolism; Cyproterone; Cyproterone Acetate; Drug Administration Schedule; Ethinyl Estradiol; Female; Glucocorticoids; Gonadotropins, Pituitary; Hirsutism; Humans; Lipid Metabolism; Menstrual Cycle; Progestins | 1986 |
Hormonal regulation of testicular descent.
Topics: Androgen Antagonists; Androgens; Animals; Blood-Testis Barrier; Chorionic Gonadotropin; Cryptorchidism; Cyproterone; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Genitalia; Gonadotropin-Releasing Hormone; Humans; Male; Mice; Mullerian Ducts; Pregnancy; Rabbits; Rats; Rats, Inbred Strains; Seminiferous Tubules; Sex Differentiation; Testis | 1983 |
Lactotroph hyperplasia in an estrogen treated male-to-female transsexual patient.
Topics: Adult; Cyproterone Acetate; Disorders of Sex Development; Ethinyl Estradiol; Humans; Hyperplasia; Klinefelter Syndrome; Magnetic Resonance Imaging; Male; Orchiectomy; Pituitary Gland; Pituitary Neoplasms; Prolactinoma | 1996 |
[Rationale for prescribing oral contraceptives].
Topics: Androgen Antagonists; Contraceptives, Oral; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethinyl Estradiol; Family Planning Services; Female; Humans; Menstrual Cycle; Progestins; Treatment Outcome | 1998 |
Acne: comparing hormonal approaches to antibiotics and isotretinoin.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Child; Cyproterone Acetate; Dermatologic Agents; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Isotretinoin; Teratogens; Tetracyclines | 2003 |
Cyproterone acetate for hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Randomized Controlled Trials as Topic | 2003 |
Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Epidemiologic Studies; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Middle Aged; Risk Assessment; Risk Factors; Thromboembolism; Venous Thrombosis | 2003 |
Medical treatment regimens of hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2005 |
New developments in hormonal therapy for acne.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 2007 |
The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review.
Topics: Algorithms; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Treatment Outcome | 2008 |
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Body Mass Index; Contraceptive Agents, Female; Cyproterone Acetate; Desogestrel; Drug Combinations; Eflornithine; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Quality of Life; Randomized Controlled Trials as Topic; Spironolactone | 2015 |
Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality.
Topics: Adalimumab; Administration, Oral; Adult; Androgen Antagonists; Anti-Bacterial Agents; Clindamycin; Cyproterone Acetate; Dermatologic Agents; Etanercept; Ethinyl Estradiol; Gentamicins; Hidradenitis Suppurativa; Humans; Infliximab; Norgestrel; Quality of Life; Treatment Outcome; Wound Closure Techniques | 2016 |
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
Topics: Adult; Clomiphene; Cyproterone Acetate; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Fertility Agents, Female; Humans; Infertility; Laparoscopy; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Suction | 2016 |
The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms - a review.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Skin Diseases; Treatment Outcome | 2017 |
Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Treatment Outcome | 2017 |
Acupuncture for polycystic ovarian syndrome.
Topics: Abortion, Spontaneous; Acupuncture Therapy; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infertility, Female; Menstruation; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Pregnancy, Multiple; Randomized Controlled Trials as Topic | 2019 |
The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
Topics: Adult; Body Mass Index; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Network Meta-Analysis; Obesity; Overweight; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone; Treatment Outcome; Triglycerides; Waist-Hip Ratio | 2021 |
Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis.
Topics: Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Testosterone | 2023 |
127 trial(s) available for ethinyl estradiol and cyproterone acetate
| Article | Year |
|---|---|
The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women.
Topics: Adolescent; Adult; Alopecia; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Therapy, Combination; Ethinyl Estradiol; Female; Ferritins; Hair; Humans; Middle Aged | 1992 |
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans | 1991 |
An open study of Triphasil and Diane 50 in the treatment of acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Synthetic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hormones; Humans; New Zealand; Norgestrel | 1991 |
[Multicentric clinical trial of a combination of 35 micrograms of ethinylestradiol and 2 mg of cyproterone acetate].
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Breast Diseases; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Pain; Uterine Hemorrhage; Virilism | 1991 |
Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Nandrolone; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1990 |
Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial.
Topics: Adult; Blood Glucose; C-Peptide; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Norpregnenes; Progesterone Congeners; Prospective Studies; Random Allocation; Reference Values | 1990 |
Cyproterone acetate/ethinyl estradiol in the treatment of acne. A comparative dose-response study of the estrogen component.
Topics: Acne Vulgaris; Adolescent; Adult; Amenorrhea; Analysis of Variance; Apolipoproteins; Body Height; Body Weight; Cholesterol; Cyproterone; Cyproterone Acetate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Testosterone; Triglycerides | 1990 |
Comparative study on the effect of Diane and Microgynon 50 contraceptive on the haemostatic mechanisms in Chinese subjects.
Topics: Adult; Asian People; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hemostasis; Humans; Norgestrel; Singapore | 1990 |
Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis.
Topics: Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Danazol; Endometriosis; Ethinyl Estradiol; Female; Humans; Pain; Pain Measurement; Pelvic Neoplasms; Pregnadienes; Random Allocation; Time Factors | 1989 |
Metabolic effects of three new low-dose pills: a six-month experience.
Topics: Adult; Androgen Antagonists; Blood Glucose; Body Weight; Cholesterol; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Norpregnenes; Progesterone Congeners; Random Allocation; Reference Values; Triglycerides | 1989 |
Effects of seven low-dose combined contraceptives on vitamin B6 status.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors | 1989 |
Hemorheological effects of oral contraceptives.
Topics: Adult; Blood Viscosity; Contraceptives, Oral; Cross-Sectional Studies; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hematocrit; Humans; Longitudinal Studies; Norgestrel; Randomized Controlled Trials as Topic; Rheology | 1989 |
Cyproterone acetate as initial treatment and maintenance therapy for hirsutism.
Topics: Adult; Androstenols; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans; Sex Hormone-Binding Globulin; Testosterone | 1985 |
Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Recurrence; Tetracycline | 1985 |
[Hirsutism treated with cyproterone acetate and ethinyl estradiol. Influence on androgens in the serum and urine and on urinary cortisol].
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Hydrocortisone; Middle Aged | 1985 |
[Hirsutism treated with cyproterone acetate and ethinyl estradiol. Evaluation of the clinical effect].
Topics: Adult; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans | 1985 |
Anti-androgen treatment in women with acne: a controlled trial.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Random Allocation | 1986 |
[Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane].
Topics: Acne Vulgaris; Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1986 |
A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa.
Topics: Adult; Androgens; Apocrine Glands; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Inflammation; Norgestrel; Sweat Gland Diseases; Sweat Glands | 1986 |
Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study.
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Breast Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Random Allocation; Time Factors | 1986 |
[Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female].
Topics: Acne Vulgaris; Adult; Alopecia; Androgen Antagonists; Clinical Trials as Topic; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstrual Cycle; Middle Aged | 1986 |
Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne. Results of a multicenter study.
Topics: Acne Vulgaris; Adolescent; Clinical Trials as Topic; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel; Random Allocation | 1986 |
Cyproterone acetate and two doses of oestrogen in female acne; a double-blind comparison.
Topics: Acne Vulgaris; Adolescent; Adult; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans | 1988 |
Antiandrogens and hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hydroxyprogesterones; Prolactin; Spironolactone; Testosterone | 1987 |
Effects of cyproterone acetate plus ethinylestradiol low dose on plasma androgens and lipids in mildly hirsute or acneic young women.
Topics: Acne Vulgaris; Adolescent; Adult; Androgens; Cyproterone; Cyproterone Acetate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Lipids; Sex Hormone-Binding Globulin; Triglycerides | 1988 |
Cyclic cyproterone/ethinyloestradiol for acne.
Topics: Acne Vulgaris; Androgen Antagonists; Animals; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Humans; Rats; Sebum | 1983 |
Clinical trial of cyproterone acetate-ethinyl oestradiol compound on androgen dependent skin disorders.
Topics: Acne Vulgaris; Adolescent; Adult; Androgens; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Male; Middle Aged; Skin Diseases | 1982 |
Antiandrogens in the treatment of acne and hirsutism.
Topics: Acne Vulgaris; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Progestins; Spironolactone; Structure-Activity Relationship; Testosterone | 1983 |
Urinary excretion of 6 beta-hydroxycortisol in women during treatment with different oral contraceptive formulations.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Norpregnenes | 1995 |
Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: efficacy, metabolic and endocrine effects.
Topics: Acne Vulgaris; Adrenocorticotropic Hormone; Blood Glucose; C-Peptide; Cyproterone Acetate; Ethinyl Estradiol; Female; Glucose Tolerance Test; Hirsutism; Humans; Hysterectomy; Insulin; Kinetics; Postmenopause; Prolactin; Prospective Studies; Retrospective Studies | 1995 |
Effects of gonadal androgens and oestrogens on adrenal androgen levels.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Androstenedione; Body Weight; Carrier Proteins; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hormones; Humans; Hydrocortisone; Luteinizing Hormone; Male; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Transsexualism | 1995 |
The effects of CTR-24, a biphasic oral contraceptive combination, compared to Diane-35 in women with acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1994 |
Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
Topics: Adult; Apoproteins; Cholesterol; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipid Metabolism; Lipoproteins; Polycystic Ovary Syndrome; Pregnancy; Testosterone; Triglycerides | 1995 |
Treatment of polycystic ovarian disease during adolescence with ethinylestradiol/cyproterone acetate versus a D-Tr-6-LHRH analog.
Topics: Adolescent; Androstenedione; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Delayed-Action Preparations; Dinoprostone; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Triptorelin Pamoate | 1993 |
The induction of ovulation with pulsatile gonadotrophin-releasing hormone (GnRH) administration in hyperandrogenic women after down-regulation with buserelin or suppression with an oral contraceptive.
Topics: Adult; Buserelin; Contraceptives, Oral, Combined; Cyproterone Acetate; Down-Regulation; Drug Combinations; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Infertility, Female; Infusion Pumps; Ovulation Induction | 1993 |
Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Tolerance; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Ultrasonography | 1993 |
Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydroxyprogesterones; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Prospective Studies; Single-Blind Method; Spironolactone; Testosterone | 1996 |
[Ovarian suppression with Diane 35/50].
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Menstrual Cycle; Treatment Outcome | 1994 |
The influence of Microgynon and Diane-35, two sub-fifty ovulation inhibitors, on voice function in women.
Topics: Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Ovulation; Phonation; Single-Blind Method | 1995 |
An open randomized comparative study of an oral contraceptive containing ethinyl estradiol and cyproterone acetate with and without the GnRH analogue goserelin in the long-term treatment of hirsutism.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral; Cyproterone Acetate; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Hirsutism; Humans; Luteinizing Hormone; Testosterone | 1996 |
Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hype
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Polycystic Ovary Syndrome; Treatment Outcome; Triptorelin Pamoate | 1997 |
Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Medroxyprogesterone Acetate; Receptors, LHRH; Remission Induction; Triptorelin Pamoate | 1997 |
Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism.
Topics: Adolescent; Adult; Cyproterone Acetate; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Mineralocorticoid Receptor Antagonists; Prospective Studies; Spironolactone; Treatment Outcome | 1998 |
Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Treatment Outcome | 1998 |
Effects of oral contraceptives containing different progestogens on sodium-lithium countertransport in normal females.
Topics: Adolescent; Adult; Antiporters; Contraceptives, Oral; Cyproterone Acetate; Desogestrel; Double-Blind Method; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Progesterone Congeners; Reference Values | 1998 |
Contraceptive and therapeutic effectiveness of two low-dose ethinylestradiol and cyproterone acetate regimens in the treatment of hirsute patients.
Topics: Adult; Contraceptives, Oral, Sequential; Cyproterone Acetate; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Progesterone; Progesterone Congeners; Severity of Illness Index | 1998 |
Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Goserelin; Hirsutism; Humans; Insulin Resistance; Lipids; Polycystic Ovary Syndrome | 1998 |
Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals.
Topics: Adipose Tissue; Adolescent; Adult; Androgen Antagonists; Anthropometry; Cyproterone Acetate; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; Sex Characteristics; Transsexualism | 1999 |
A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Topics: Adult; Cyproterone Acetate; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Hormones; Humans; Ketoconazole; Prospective Studies | 1999 |
[The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
Topics: Acne Vulgaris; Administration, Oral; Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Face; Female; Germany; Hirsutism; Humans; Progesterone Congeners; Treatment Outcome | 1999 |
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Single-Blind Method; Treatment Outcome | 2000 |
Spironolactone as a single agent for long-term therapy of hirsute patients.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Testosterone | 2000 |
Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Androgen Antagonists; Constriction; Cyproterone Acetate; Endothelium, Vascular; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Male; Testosterone; Tissue Plasminogen Activator; Transsexualism; Veins | 2000 |
Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile.
Topics: Adolescent; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipids; Polycystic Ovary Syndrome | 2000 |
[Long-term side-effects following cyproterone acetate containing therapy in gynecology].
Topics: Adult; Androgen Antagonists; Carcinoma, Hepatocellular; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans; Liver Neoplasms; Risk Factors | 2000 |
Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
Topics: Adult; Androgen Antagonists; Area Under Curve; Blood Glucose; Calorimetry; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Fats; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome | 2000 |
Long-term GnRH analogue treatment is equivalent to laparoscopic laser diathermy in polycystic ovarian syndrome patients with severe ovarian dysfunction.
Topics: Adult; Androgen Antagonists; Chorionic Gonadotropin; Clomiphene; Cyproterone Acetate; Drug Combinations; Electrocoagulation; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Laparoscopy; Lasers; Leuprolide; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Prospective Studies; Recombinant Proteins | 2000 |
Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
Topics: Adult; Amenorrhea; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol; Estradiol Congeners; Estrone; Ethinyl Estradiol; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Luteinizing Hormone; Luteolytic Agents; Polycystic Ovary Syndrome; Progesterone Congeners; Prospective Studies; Triptorelin Pamoate | 2000 |
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Androstenedione; Body Mass Index; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone | 2001 |
[Comparison of 2 therapeutic strategies in severe endometriosis, in young women consulting for sterility or pain. II. In the case of infertility, value of ovarian stimulation with intrauterine insemination after surgery].
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Insemination, Artificial; Laparoscopy; Ovulation Induction; Pregnancy; Recurrence; Retrospective Studies | 2001 |
Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Severity of Illness Index | 2001 |
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Apolipoprotein A-I; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Lipids; Polycystic Ovary Syndrome; Severity of Illness Index; Triglycerides | 2002 |
Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
Topics: Administration, Topical; Adult; Alopecia; Androgen Antagonists; Body Mass Index; Contraceptives, Oral, Combined; Cyproterone Acetate; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Minoxidil | 2002 |
Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study.
Topics: Adolescent; Adult; Androstenedione; Body Constitution; Body Mass Index; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin | 2002 |
Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women.
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Melatonin | 2002 |
Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
Topics: Adult; Contraceptives, Oral; Cyproterone Acetate; Drug Combinations; Energy Metabolism; Estradiol Congeners; Ethinyl Estradiol; Fatty Acids, Nonesterified; Female; Hormones; Humans; Hypoglycemic Agents; Lipid Metabolism; Lipids; Metformin; Oxidation-Reduction; Polycystic Ovary Syndrome | 2003 |
Treatment of hyperandrogenic alopecia in women.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Androgen Antagonists; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Hyperandrogenism; Italy; Liver; Testosterone | 2003 |
Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism.
Topics: Administration, Oral; Adult; Androgen Antagonists; Contraceptives, Oral; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Liver Function Tests; Prolactin; Severity of Illness Index; Testosterone; Treatment Outcome | 2002 |
Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments.
Topics: Administration, Oral; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Leptin; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Steroids | 2003 |
Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Spironolactone; Testosterone | 2003 |
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.
Topics: Adult; Anthropometry; Blood Glucose; Body Weight; C-Peptide; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Hormones; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome | 2003 |
Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Anthropometry; Blood Glucose; Blood Pressure; Body Mass Index; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Polycystic Ovary Syndrome; Sebum | 2003 |
Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.
Topics: Adult; C-Reactive Protein; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Obesity; Polycystic Ovary Syndrome; Progesterone Congeners | 2003 |
Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Appetite Depressants; Blood Pressure; Body Constitution; Body Weight; Cyclobutanes; Cyproterone Acetate; Diastole; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Obesity; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides | 2003 |
Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormone Antagonists; Hormones; Humans; Incidence; Infertility, Female; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pilot Projects; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Premedication | 2004 |
[Combined use of metformin and Diane35 in polycystic ovary syndrome].
Topics: Administration, Oral; Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Treatment Outcome | 2004 |
Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies | 2004 |
Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects.
Topics: Adult; Aged; Aromatase Inhibitors; Cyproterone Acetate; Docosahexaenoic Acids; Estradiol; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Male; Middle Aged; Sex Characteristics; Testosterone; Transsexualism | 2004 |
Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Body Mass Index; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Waist-Hip Ratio | 2005 |
Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes.
Topics: Administration, Oral; Adult; Androgens; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyproterone Acetate; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Treatment Outcome; Triglycerides | 2004 |
Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cardiovascular Diseases; Cholesterol; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Obesity; Polycystic Ovary Syndrome; Treatment Outcome | 2005 |
Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma.
Topics: Adult; Analysis of Variance; Androgen Antagonists; Biomarkers; Cyproterone Acetate; Erythropoiesis; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Growth Hormone; Hematocrit; Hemoglobins; Humans; Insulin-Like Growth Factor I; Male; Receptors, Transferrin; Testosterone; Time Factors; Transsexualism | 2005 |
Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
Topics: Adolescent; Adult; Androgens; Blood Glucose; Cholesterol, HDL; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Insulin Resistance; Middle Aged; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones | 2006 |
[Clinical research on combined therapy of diane-35 with modified yougui pill on polycystic ovarian syndrome].
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Humans; Phytotherapy; Polycystic Ovary Syndrome; Tablets | 2005 |
Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Diuretics; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Treatment Outcome | 2005 |
Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Contraceptives, Oral; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Folic Acid; Homocysteine; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Vitamin B 12 | 2006 |
Plasma ghrelin concentrations in patients with polycystic ovary syndrome before and after 6months therapy: correlation with androgen levels.
Topics: Adult; Androgen Antagonists; Androgens; Androstenedione; Cyproterone Acetate; Dehydroepiandrosterone; Drug Combinations; Ethinyl Estradiol; Female; Ghrelin; Humans; Peptide Hormones; Polycystic Ovary Syndrome; Testosterone | 2006 |
Weight change and androgen levels during contraceptive treatment of women affected by polycystic ovary.
Topics: Adult; Androgens; Body Weight; Contraception; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipids; Polycystic Ovary Syndrome; Weight Gain | 2006 |
The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Endothelin-1; Estradiol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome | 2008 |
Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.
Topics: Administration, Oral; Adult; Androgen Antagonists; Androgens; Blood Glucose; Cardiovascular Diseases; Cyproterone Acetate; Drug Combinations; Dyslipidemias; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Polycystic Ovary Syndrome; Risk Factors | 2007 |
Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Ferritins; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Iron; Metformin; Obesity; Oligomenorrhea; Polycystic Ovary Syndrome | 2007 |
The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicular Phase; Homocysteine; Humans; Lipids; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2008 |
Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
Topics: Adolescent; Adult; Body Mass Index; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Metformin; Obesity; Polycystic Ovary Syndrome; Risk Factors; Uric Acid | 2008 |
Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Lipids; Prospective Studies; Spironolactone; Young Adult | 2008 |
Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects.
Topics: Adolescent; Adult; Amino Acids, Aromatic; Cyproterone Acetate; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Male; Models, Biological; Neurotransmitter Agents; Phenylalanine; Substrate Specificity; Synaptic Transmission; Testosterone; Transsexualism; Tryptophan; Tyrosine | 2008 |
Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carotid Arteries; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hypertension; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Tunica Intima; Young Adult | 2009 |
Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Topics: Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Fasting; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Insulin; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Waist-Hip Ratio | 2008 |
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Vasodilation; von Willebrand Factor | 2010 |
Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.
Topics: Adult; Androgen Antagonists; Blood Coagulation; Blood Platelets; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Endothelium, Vascular; Ethinyl Estradiol; Female; Fibrinogen; Homocysteine; Humans; Hypoglycemic Agents; Metformin; Obesity; Partial Thromboplastin Time; Polycystic Ovary Syndrome; Prothrombin; Smoking; Young Adult | 2009 |
Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral; Cyproterone Acetate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Middle Aged; Nandrolone; Young Adult | 2009 |
Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
Topics: Adult; Blood Coagulation; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Weight Loss; Young Adult | 2010 |
Oral hormonal contraceptives affect the concentration and composition of urinary glycosaminoglycans in young women.
Topics: Adult; Androstenes; Chondroitin Sulfates; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dermatan Sulfate; Ethinyl Estradiol; Female; Glycosaminoglycans; Heparitin Sulfate; Humans; Norpregnenes | 2009 |
The effect of ethinylestradiol (EE)/cyproterone acetate (CA) and EE/CA plus metformin treatment on adhesion molecules in cases with polycystic ovary syndrome (PCOS).
Topics: Adult; Antineoplastic Agents; Cell Adhesion Molecules; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Young Adult | 2009 |
Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patients.
Topics: Adolescent; Adult; CD40 Antigens; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Young Adult | 2010 |
Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients.
Topics: Adult; Androgen Antagonists; Body Mass Index; CD40 Antigens; Contraceptives, Oral; Cyproterone Acetate; Dose-Response Relationship, Drug; Down-Regulation; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Young Adult | 2011 |
The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Anti-Mullerian Hormone; Blood Glucose; Body Mass Index; Cohort Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Practice Guidelines as Topic; Young Adult | 2011 |
Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Severity of Illness Index; Spironolactone; Time Factors; Treatment Outcome; Young Adult | 2012 |
Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Pilot Projects; Polycystic Ovary Syndrome; Prospective Studies; Regression Analysis; Vasodilation; Young Adult | 2011 |
[Hormonal treatment effectivity in hyperandrogenic syndrome].
Topics: Adult; Androgen Antagonists; Androstenes; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Syndrome | 2010 |
Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate.
Topics: Adolescent; Adult; Blood Viscosity; Body Mass Index; Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fibrinogen; Humans; Polycystic Ovary Syndrome; Triglycerides; Young Adult | 2011 |
Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.
Topics: Abdominal Fat; Adolescent; Androgen Antagonists; Body Composition; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Metformin; Pioglitazone; Thiazolidinediones; Treatment Outcome | 2011 |
Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Humans; Metformin; Phytotherapy; Polycystic Ovary Syndrome; Young Adult | 2011 |
Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women.
Topics: Absorptiometry, Photon; Adolescent; Adolescent Development; Bone and Bones; Bone Density; Bone Development; Bone Resorption; China; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Femur Neck; Humans; Lumbar Vertebrae; Medication Adherence; Patient Dropouts | 2012 |
Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue.
Topics: Abdominal Fat; Adolescent; Androgen Antagonists; Angiopoietin-Like Protein 4; Angiopoietins; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Body Composition; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Flutamide; Gene Expression; Humans; Hyperandrogenism; Hypoglycemic Agents; Leptin; Metformin; Pioglitazone; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Subcutaneous Fat; Thiazolidinediones; TWEAK Receptor | 2012 |
Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.
Topics: Adiposity; Adolescent; Adolescent Development; Androgen Antagonists; Body Mass Index; C-Reactive Protein; Carotid Intima-Media Thickness; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Menstruation Disturbances; Overweight; Tunica Intima; Vascular Diseases | 2013 |
A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cross-Over Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hyperandrogenism; Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Prospective Studies; Quality of Life; Severity of Illness Index; Testosterone; Young Adult | 2014 |
Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Androstenes; Biomarkers; Body Mass Index; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Lipids; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Polycystic Ovary Syndrome; Treatment Outcome; Turkey; Waist-Hip Ratio | 2014 |
Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Androgens; Androstenedione; Cholesterol; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipoproteins, HDL; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Young Adult | 2015 |
[Efficacy comparison between electroacupuncture and dyne-35 in treatment of polycystic ovary syndrome].
Topics: Acupuncture Points; Adolescent; Adult; Cyproterone Acetate; Drug Combinations; Electroacupuncture; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Young Adult | 2014 |
Effects of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess.
Topics: Adolescent; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Fibroblast Growth Factors; Flutamide; Hirsutism; Humans; Hyperandrogenism; Hyperinsulinism; Longitudinal Studies; Metformin; Pioglitazone; Thiazolidinediones | 2016 |
[
Topics: Acupuncture Points; Acupuncture Therapy; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Ovary; Pilot Projects; Polycystic Ovary Syndrome | 2017 |
Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Treatment Outcome | 2018 |
Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
Topics: Adult; Androgen Antagonists; Androgens; Body Mass Index; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Metformin; Ovary; Polycystic Ovary Syndrome; Prospective Studies; Regional Blood Flow; Testosterone; Ultrasonography, Doppler, Color; Waist Circumference | 2019 |
The efficacy of Tung's acupuncture for sex hormones in polycystic ovary syndrome: A randomized controlled trial.
Topics: Acupuncture; Acupuncture Therapy; Adult; Body Mass Index; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Polycystic Ovary Syndrome | 2019 |
Is There An Advantage of Using Dingkun Pill () alone or in Combination with Diane-35 for Management of Polycystic Ovary Syndrome? A Randomized Controlled Trial.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2020 |
Therapeutic effects of puerarin on polycystic ovary syndrome: A randomized trial in Chinese women.
Topics: Administration, Oral; Adolescent; Adult; China; Cholesterol; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Isoflavones; Metformin; Obesity; Polycystic Ovary Syndrome; Primary Ovarian Insufficiency; Sex Hormone-Binding Globulin; Superoxide Dismutase; Tablets; Testosterone; Treatment Outcome; Young Adult | 2021 |
Bloodletting has no effect on the blood pressure abnormalities of hyperandrogenic women taking oral contraceptives in a randomized clinical trial.
Topics: Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bloodletting; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypertension; Polycystic Ovary Syndrome; Young Adult | 2021 |
231 other study(ies) available for ethinyl estradiol and cyproterone acetate
| Article | Year |
|---|---|
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Influence of oral contraceptive agents on kidney function and protein metabolism.
Topics: Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Dietary Proteins; Drug Combinations; Ethinyl Estradiol; Female; Germany; Glomerular Filtration Rate; Humans; Kidney; Norpregnenes | 1992 |
Salivary testosterone as an index of antiandrogen therapy in hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Chi-Square Distribution; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstrual Cycle; Saliva; Testosterone | 1992 |
Therapeutic alternatives for the hirsute woman.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Retrospective Studies; Spironolactone; Trinidad and Tobago | 1992 |
Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
Topics: Adolescent; Adult; Carrier Proteins; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Luteinizing Hormone; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1991 |
A role for a non-androgenic anovulant in the management of hirsutism.
Topics: Androgen Antagonists; Androstenedione; Cyproterone; Cyproterone Acetate; Dexamethasone; Drug Combinations; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans; Testosterone | 1991 |
Minocycline-induced pigmentation occurring in two sisters.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Ethinyl Estradiol; Family; Female; Humans; Minocycline; Pigmentation Disorders; Skin Pigmentation | 1991 |
[Ischemic colitis caused by estrogen-antiestrogen combination].
Topics: Adult; Androgen Antagonists; Colitis; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Ischemia | 1991 |
Is plasma 5 alpha-androstane 3 alpha, 17 beta-diol glucuronide a biochemical marker of hirsutism in women?
Topics: Adult; Androgen Antagonists; Androstane-3,17-diol; Biomarkers; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Polycystic Ovary Syndrome | 1991 |
Endometrial patterns during danazol and cyproterone acetate treatment for endometriosis: structural and ultrastructural study.
Topics: Adult; Biopsy; Cyproterone; Cyproterone Acetate; Danazol; Drug Combinations; Endometriosis; Endometrium; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone | 1991 |
[Long-term studies with an anti-androgen/estrogen combination preparation of its effectiveness, liver tolerance and lipid metabolism in females].
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cholesterol, HDL; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans; Lipids; Liver Function Tests; Long-Term Care; Menstrual Cycle; Middle Aged | 1991 |
The polycystic ovary syndrome presenting as resistant acne successfully treated with cyproterone acetate.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dexamethasone; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome | 1991 |
On treating acne vulgaris with antiandrogens.
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans | 1991 |
Deep venous thrombosis and antibodies to cyproterone acetate.
Topics: Adult; Androgen Antagonists; Antibodies; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Iliac Vein; Thrombosis | 1990 |
Metabolic effect at six and twelve months of cyproterone acetate (2 mg) combined with ethinyl estradiol (35 micrograms) in 31 patients.
Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Lipoproteins; Triglycerides | 1990 |
The ovary-suppression test in the evaluation of hyperandrogenemia.
Topics: Adolescent; Adrenal Glands; Adult; Androgens; Body Mass Index; Body Weight; Cyproterone; Cyproterone Acetate; Dexamethasone; Ethinyl Estradiol; Female; Hirsutism; Humans; Oligomenorrhea; Ovary; Progesterone; Regression Analysis; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Reduced serum vitamin B12 levels during oral cyproterone-acetate and ethinyl-oestradiol therapy in women with diffuse androgen-dependent alopecia.
Topics: Administration, Oral; Alopecia; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Vitamin B 12 | 1990 |
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
Topics: Acne Vulgaris; Adult; Alanine Transaminase; Alkaline Phosphatase; Analysis of Variance; Androgen Antagonists; Androstenedione; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Cholesterol; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Liver; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1990 |
[Anti-androgen treatment of hirsutism with cyproterone acetate].
Topics: Administration, Oral; Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Injections, Intramuscular | 1990 |
Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Apolipoproteins; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Lipid Metabolism; Male; Polycystic Ovary Syndrome; Triglycerides | 1990 |
Hereditary angioedema and oral contraception.
Topics: Adult; Androgen Antagonists; Angioedema; Contraceptives, Oral; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1990 |
Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1989 |
The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals.
Topics: Adult; Bone and Bones; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Humans; Male; Middle Aged; Transsexualism | 1989 |
The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females.
Topics: Adolescent; Adult; Alopecia; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Hair; Humans | 1989 |
Ultrasound study of ovarian and uterine morphology in women with polycystic ovary syndrome before, during and after treatment with cyproterone acetate and ethinyloestradiol.
Topics: Adolescent; Adult; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstrual Cycle; Ovary; Ovulation; Polycystic Ovary Syndrome; Time Factors; Ultrasonography; Uterus | 1985 |
[Current status of gynecologic hormone therapy. Hyperandrogen disorders].
Topics: Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infertility, Female; Testosterone | 1985 |
Comments on 'Conception during 'Diane' therapy--a successful outcome'.
Topics: Cyproterone; Cyproterone Acetate; Drug Combinations; Embryonic and Fetal Development; Ethinyl Estradiol; Female; Humans; Male; Pregnancy | 1986 |
The effect of cyproterone acetate alone and in combination with ethinylestradiol on the hypothalamic pituitary adrenal axis, prolactin and growth hormone release in male-to-female transsexuals.
Topics: Adult; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Prolactin; Time Factors; Transsexualism | 1986 |
On therapeutic approaches to some special types of acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Androgen Antagonists; Anti-Inflammatory Agents; Benzoyl Peroxide; Clindamycin; Cyproterone; Cyproterone Acetate; Diazepam; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Erythromycin; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Male; Sulfamethoxazole; Tetracycline; Tretinoin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Paradoxical effects of the anti-androgen cyproterone acetate on lipid and lipoprotein metabolism.
Topics: Acne Vulgaris; Adult; Cholesterol; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Lipid Metabolism; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Triglycerides | 1986 |
The management of acne in general practice.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Cyproterone; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Family Practice; Female; Humans; Male | 1985 |
Effects on the lipoprotein metabolism of an antiandrogen-estrogen oral contraceptive drug.
Topics: Acne Vulgaris; Adolescent; Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Lipoproteins; Lipoproteins, VLDL; Phospholipids; Triglycerides | 1986 |
Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy.
Topics: Adult; Androgens; Apocrine Glands; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Inflammation; Sebum; Sex Hormone-Binding Globulin; Sweat Gland Diseases; Sweat Glands | 1986 |
Pulmonary embolism after short-term treatment of acne vulgaris with ovulation suppressor agents.
Topics: Acne Vulgaris; Adult; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Pulmonary Embolism; Smoking | 1986 |
[Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
Topics: Acne Vulgaris; Adolescent; Adult; Alopecia; Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans | 1986 |
Effect of cyproterone acetate-ethinyl estradiol treatment on the proportions of linoleic and sebaleic acids in various skin surface lipid classes.
Topics: Acne Vulgaris; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Linoleic Acids; Sebum; Skin | 1986 |
Effects of a cyproterone-containing oral contraceptive on hormonal levels in polycystic ovarian disease.
Topics: Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Pituitary Hormones; Polycystic Ovary Syndrome | 1987 |
Effects of cyproterone acetate (CPA) on serum lipoproteins when administered alone and in combination with ethinyl estradiol (EE).
Topics: Adult; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Ovariectomy; Triglycerides | 1987 |
Liver structure and function during long-term treatment with cyproterone acetate.
Topics: Adult; Cyproterone; Cyproterone Acetate; Drug Evaluation; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Liver; Liver Function Tests; Middle Aged; Time Factors; Ultrasonography; Virilism | 1987 |
The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parameters.
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Erythrocyte Count; Ethinyl Estradiol; Hematocrit; Hemoglobins; Hirsutism; Humans; Prospective Studies; Testosterone | 1987 |
Androgen action blockade does not result in reduction in size but changes histology of the normal human prostate.
Topics: Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Follicle Stimulating Hormone; Humans; Imidazoles; Imidazolidines; Luteinizing Hormone; Male; Prolactin; Prostate; Testosterone | 1987 |
Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol.
Topics: Adult; Androgens; Androstenedione; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hair; Hirsutism; Humans; Luteinizing Hormone; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1987 |
[A cyproterone acetate-ethinyl estradiol combination in the treatment of acne. Data of a survey of gynecologists].
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Gynecology; Humans; Surveys and Questionnaires | 1988 |
Suitability of cyproterone acetate in the treatment of osteoporosis associated with athletic amenorrhea.
Topics: Adolescent; Adult; Amenorrhea; Bone and Bones; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Humans; Luteinizing Hormone; Minerals; Osteoporosis; Progesterone; Sports | 1988 |
[Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent--acne therapeutic drug is effective as a contraceptive].
Topics: Acne Vulgaris; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1988 |
The treatment of a hyperandrogenic and virilizing state in an elderly female with a synthetic LHRH agonist.
Topics: Aged; Aged, 80 and over; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Hydrocortisone; Testosterone; Triptorelin Pamoate; Virilism | 1988 |
Effects of antiandrogen-estrogen treatment on sexual and endocrine parameters in hirsute women.
Topics: Adolescent; Adult; Coitus; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Masturbation; Sex Hormone-Binding Globulin; Sexual Behavior; Testosterone | 1988 |
[Pregnancy carried to term following administration of cyproterone acetate in the 1st trimester].
Topics: Abnormalities, Drug-Induced; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Trimester, First | 1988 |
Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Estradiol; Estrogens; Ethinyl Estradiol; Humans; Male; Middle Aged; Pituitary Gland; Prolactin; Transsexualism | 1988 |
[Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
Topics: Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Ovulation; Progesterone | 1986 |
Urethral obstruction secondary to carcinoma of prostate: response to endocrine treatment.
Topics: Adenocarcinoma; Aged; Castration; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Humans; Male; Middle Aged; Prostatic Neoplasms; Urethral Obstruction | 1985 |
Follow-up of prolactin levels in long-term oestrogen-treated male-to-female transsexuals with regard to prolactinoma induction.
Topics: Adolescent; Adult; Cyproterone; Cyproterone Acetate; Dopamine; Ethinyl Estradiol; Female; Galactorrhea; Humans; Male; Middle Aged; Monoiodotyrosine; Pituitary Neoplasms; Pregnancy; Prolactin; Time Factors; Transsexualism | 1985 |
Oral contraceptives and pituitary response to GnRH: comparative study of progestin-related effects.
Topics: Adult; Contraceptives, Oral; Cyproterone; Cyproterone Acetate; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Norethindrone; Pituitary Gland; Progestins | 1985 |
Activation of PRL secretion by combined treatment with cyproterone acetate and ethinylestradiol.
Topics: Adult; Cyproterone; Cyproterone Acetate; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Pituitary Gland; Prolactin; Testosterone; Thyroxine; Triiodothyronine | 1985 |
[Effects of an anti-androgen combination preparation on the hemostatic system].
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk; Thrombosis | 1987 |
Marked deciliation and insufficient secretory modification of endometrial surface during treatment with a new progestogen-estrogen combination.
Topics: Adolescent; Adult; Androgen Antagonists; Cilia; Cyproterone; Cyproterone Acetate; Drug Combinations; Endometrium; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Microscopy, Electron, Scanning | 1987 |
A comparative study of Aldactone and Diane in the treatment of hirsutism.
Topics: Adolescent; Adult; Cyproterone; Cyproterone Acetate; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hirsutism; Humans; Pituitary Hormones, Anterior; Sex Hormone-Binding Globulin; Spironolactone | 1987 |
Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives.
Topics: Animals; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Luteinizing Hormone; Norethindrone; Norgestrel; Norpregnenes; Rats | 1984 |
[A case of Stein-Leventhal syndrome].
Topics: Adult; Clomiphene; Cyproterone; Cyproterone Acetate; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome | 1984 |
Is cyclic low dose cyproterone acetate and ethinyloestradiol effective in acne?
Topics: Acne Vulgaris; Adolescent; Adult; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Sebum | 1983 |
Cyclic cyproterone/ethinyloestradiol for acne.
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1983 |
Cyclic cyproterone/ethinyloestradiol for acne.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Humans; Sex Factors | 1983 |
Cyclic cyproterone/ethinyloestradiol in acne.
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Humans | 1983 |
Cyproterone acetate in the treatment of acne vulgaris in adult females.
Topics: 17-Ketosteroids; Acne Vulgaris; Adult; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Testosterone | 1982 |
Salivary testosterone: relationship to unbound plasma testosterone in normal and hyperandrogenic women.
Topics: Adolescent; Adult; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Radioimmunoassay; Saliva; Testosterone | 1982 |
The effect of cyproterone acetate on pituitary-ovarian function and clinical symptoms in hirsute women.
Topics: Adrenal Glands; Adult; Androstenedione; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Ovary; Pituitary Gland; Testosterone | 1982 |
Distribution and percentages of non-protein bound contraceptive steroids in human serum.
Topics: Carrier Proteins; Centrifugation; Cyproterone; Cyproterone Acetate; Dialysis; Ethinyl Estradiol; Female; Humans; Male; Norethindrone; Norgestrel; Pregnancy; Serum Albumin; Sex Hormone-Binding Globulin; Ultrafiltration | 1982 |
The treatment of acne with an anti-androgen/oestrogen combination.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral; Cyproterone; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Tetracycline | 1982 |
Assay of some endogenous and synthetic sex steroids for tumor-initiating activity in rat liver using the Solt-Farber system.
Topics: Androgen Antagonists; Animals; Carcinogens; Cyproterone; Cyproterone Acetate; Estradiol; Ethinyl Estradiol; Liver Neoplasms; Male; Neoplasms, Experimental; Norethindrone; Norethindrone Acetate; Norethynodrel; Progesterone; Rats; Rats, Inbred F344 | 1983 |
[Treatment of severe acne in women with Diane (cyproteronacetate and ethinylestradiol)].
Topics: Acne Vulgaris; Adolescent; Adult; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1982 |
[Use of cyproterone acetate in the treatment of acne].
Topics: Acne Vulgaris; Adolescent; Adult; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Female; Humans | 1982 |
Plasma and salivary androstenedione and dihydrotestosterone in women with hyperandrogenism.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Radioimmunoassay; Saliva | 1983 |
[Treatment of moderately severe virilism of women with Diane and Androcur 10].
Topics: Acne Vulgaris; Adolescent; Adult; Alopecia; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Virilism | 1983 |
Cyproterone acetate and the treatment of hirsutism.
Topics: Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Lipids | 1983 |
Effect of cyproterone acetate on glucocorticoid secretion in patients treated for hirsutism.
Topics: 17-Hydroxycorticosteroids; Contraceptives, Oral, Combined; Cortodoxone; Cosyntropin; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Hydrocortisone | 1983 |
Effect of estrogens on luteinizing hormone release in testicular feminization syndrome before and after gonadectomy.
Topics: Adolescent; Adult; Androgen-Insensitivity Syndrome; Castration; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Testosterone | 1984 |
Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen.
Topics: Adult; Androgen Antagonists; Androgens; Chronic Disease; Cyproterone; Cyproterone Acetate; Drug Evaluation; Ethinyl Estradiol; Female; Hirsutism; Humans; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1984 |
Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Androstenediol; Androstenedione; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Ethinyl Estradiol; Female; Hirsutism; Humans; Sex Hormone-Binding Globulin; Testosterone | 1984 |
[Cyproterone acetate (2 mg) controversy].
Topics: Acne Vulgaris; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Sebum | 1984 |
Effective medical treatment of common baldness in women.
Topics: Adolescent; Adult; Alopecia; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hormones; Humans | 1984 |
[Experiences in dermatologic practice with combined external treatment of acne with benzoyl peroxide and erythromycin].
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Benzoyl Peroxide; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Erythromycin; Ethinyl Estradiol; Female; Humans; Male; Peroxides; Tetracycline; Ultraviolet Therapy | 1984 |
Treatment of idiopathic hirsute women with two combinations of cyproterone acetate.
Topics: Adolescent; Adult; Cyproterone; Cyproterone Acetate; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Kidney Function Tests; Liver Function Tests; Luteinizing Hormone; Progesterone; Prolactin; Testosterone; Time Factors | 1983 |
The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism.
Topics: Acne Vulgaris; Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Fasting; Female; Glucose Tolerance Test; Hirsutism; Humans; Insulin; Insulin Resistance; Tolbutamide | 1984 |
Effects of antiandrogen treatment on the sexuality of women with hyperandrogenism.
Topics: Acne Vulgaris; Adult; Alopecia; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Libido; Sexual Behavior | 1984 |
Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androstenedione; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Hydrocortisone; Hydroxyprogesterones; Pregnenolone; Progesterone; Testosterone | 1982 |
Effect of cyproterone acetate-ethinyl oestradiol treatment on adrenal function in hirsute women.
Topics: Adrenocorticotropic Hormone; Adult; Circadian Rhythm; Cyproterone; Cyproterone Acetate; Depression, Chemical; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Hydrocortisone; Insulin; Pituitary-Adrenal System | 1982 |
[Clinical use of antiandrogens in the female].
Topics: Acne Vulgaris; Adrenocorticotropic Hormone; Alopecia; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hypertrichosis; Luteinizing Hormone; Pregnancy; Prolactin; Virilism | 1980 |
Urinary oxalate excretion during anti-androgenic therapy.
Topics: Aged; Castration; Cyproterone; Cyproterone Acetate; Estradiol; Ethinyl Estradiol; Humans; Male; Middle Aged; Organophosphorus Compounds; Oxalates; Prostatic Neoplasms; Testosterone | 1980 |
The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women.
Topics: Adult; Androgens; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Sex Hormone-Binding Globulin; Testosterone | 1980 |
The treatment of essential hirsutism in women with cyproterone acetate and ethinyl estradiol. Clinical and endocrine effects in 10 cases.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Progesterone; Testosterone | 1981 |
[Anti-androgens. Their use in dermatology].
Topics: Acne Vulgaris; Adolescent; Adult; Alopecia; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Hirsutism; Humans; Hydrocortisone; Middle Aged; Testosterone | 1981 |
[Management of virilization with an antiandrogen-containing contraceptive].
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Testosterone; Virilism | 1981 |
Cholesterol ester metabolism in plasma during estrogen and antiandrogen treatment in men with carcinoma of the prostate.
Topics: Aged; Castration; Cholesterol Esters; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Humans; Lipoproteins; Male; Middle Aged; Organophosphorus Compounds; Phosphatidylcholine-Sterol O-Acyltransferase; Prostatic Neoplasms | 1981 |
Effect of cyproterone acetate on rate of hair growth in hirsute females.
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hair; Hirsutism; Humans; Reference Values | 1981 |
[Decrease of the sebum excretion rate and improvement of acne in acneic women treated with the association: cyproterone acetate-ethinyl estradiol (author's transl)].
Topics: Acne Vulgaris; Adolescent; Adult; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Sebum; Time Factors | 1981 |
[Diagnosis and treatment of hirsutism].
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dexamethasone; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Spironolactone | 1984 |
[Diane].
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Skin Diseases | 1983 |
Porphyria variegata treated with cyproterone acetate and ethinyl estradiol.
Topics: Abdomen; Adult; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Pain; Porphyrias; Skin Diseases | 1983 |
[Clinical treatment results of treating androgenization symptoms in women with preparation Diane-35].
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Remission Induction; Treatment Outcome; Virilism | 1994 |
Lupus-like syndrome in patients treated for acne.
Topics: Acne Vulgaris; Adolescent; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Lupus Erythematosus, Systemic; Minocycline | 1995 |
Induction of insulin resistance by androgens and estrogens.
Topics: Adolescent; Adult; Blood Glucose; Carrier Proteins; Cyproterone Acetate; Ethinyl Estradiol; Female; Glucose Clamp Technique; Humans; Hydrocortisone; Insulin; Insulin Resistance; Male; Sex Hormone-Binding Globulin; Testosterone | 1994 |
Frequency and treatment of ovarian cysts in adolescence.
Topics: Adolescent; Androgen Antagonists; Child; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Ovarian Cysts; Time Factors; Ultrasonography | 1994 |
Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.
Topics: Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Half-Life; Humans; Menstrual Cycle; Sex Hormone-Binding Globulin; Testosterone | 1993 |
Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
Topics: Adult; Androgen Antagonists; Androgens; Contraceptives, Oral; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome | 1993 |
Influence of sex hormones on plasma endothelin levels.
Topics: Adolescent; Adult; Cyproterone Acetate; Drug Combinations; Endothelins; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Male; Pregnancy; Sex Characteristics; Testosterone; Transsexualism | 1993 |
Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism.
Topics: Adult; C-Peptide; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Metabolic Clearance Rate | 1993 |
Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease.
Topics: Adult; Contraceptives, Oral; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Leuprolide; Polycystic Ovary Syndrome | 1996 |
Absence of antisteroid antibodies in oral contraceptive users presenting with vascular events.
Topics: Adolescent; Adult; Androgen Antagonists; Antibodies; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Immunoenzyme Techniques; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes; Progesterone Congeners; Thrombophlebitis | 1995 |
Overdiagnosis of 21-hydroxylase late onset congenital adrenal hyperplasia: correlation of corticotropin test and human leukocyte antigen typing.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Cyproterone Acetate; Ethinyl Estradiol; Female; Follow-Up Studies; Histocompatibility Testing; Humans; Hydroxyprogesterones; Progesterone | 1996 |
Skin ulcers in a young woman on low-dose estrogen-combination pill.
Topics: Adult; Anemia, Macrocytic; Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Folic Acid Deficiency; Humans; Leg Ulcer | 1997 |
Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents.
Topics: Adolescent; Adult; Androgen Antagonists; Body Weight; Child; Cyproterone Acetate; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation Disturbances; Ovary; Polycystic Ovary Syndrome; Singapore; Testosterone; Ultrasonography | 1997 |
Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females.
Topics: Androgen Antagonists; Creatinine; Cyproterone Acetate; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Homocysteine; Humans; Male; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone; Transsexualism | 1998 |
Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Menstrual Cycle; Sex Hormone-Binding Globulin; Testosterone | 1998 |
Effects on bone mass of two oral contraceptives containing ethinylestradiol and cyproterone acetate or desogestrel: results of a 2-year follow-up.
Topics: Adult; Bone Density; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hirsutism; Humans; Progesterone Congeners | 1998 |
Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals.
Topics: Adolescent; Adult; Androgen Antagonists; Cognition; Cyproterone Acetate; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Sex Characteristics; Testosterone; Time Factors; Transsexualism | 1999 |
Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome.
Topics: Adult; Androgens; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Electrocoagulation; Estrogens; Ethinyl Estradiol; Female; Gonadotropins; Humans; Hyperandrogenism; Infertility, Female; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1999 |
[Systemic treatment of acne: proposal. The French Agency of Sanitary Safety of Health Products].
Topics: Acne Vulgaris; Administration, Oral; Androgen Antagonists; Anti-Bacterial Agents; Cyproterone Acetate; Dermatologic Agents; Estradiol Congeners; Ethinyl Estradiol; Follow-Up Studies; Gluconates; Humans; Isotretinoin; Keratolytic Agents; Lithium; Zinc | 1999 |
[Systemic treatment of acne: recommendations. The French Agency of Sanitary Safety of Health Products].
Topics: Acne Vulgaris; Administration, Oral; Androgen Antagonists; Anti-Bacterial Agents; Cyproterone Acetate; Dermatologic Agents; Estradiol Congeners; Ethinyl Estradiol; Gluconates; Humans; Isotretinoin; Keratolytic Agents; Lithium; Zinc | 1999 |
Mammary fibroadenoma in a male-to-female transsexual.
Topics: Adult; Breast Neoplasms, Male; Cyproterone Acetate; Ethinyl Estradiol; Fibroadenoma; Humans; Male; Orchiectomy; Transsexualism | 1999 |
Oral contraceptives that contain ethinyl estradiol (0.035 mg) and cyproterone acetate (2 mg) inhibit leukocyte transmigration through endothelial cell monolayers.
Topics: Cell Adhesion; Cells, Cultured; Contraceptives, Oral; Cyproterone Acetate; Endothelium, Vascular; Estradiol Congeners; Ethinyl Estradiol; Humans; Infant, Newborn; Neutrophil Infiltration; Neutrophils | 1999 |
Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men.
Topics: Adult; Aged; Androgen Antagonists; Anilides; Breast; Castration; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Flutamide; Follow-Up Studies; Gynecomastia; Humans; Male; Mastectomy, Subcutaneous; Metaplasia; Nitriles; Orchiectomy; Time Factors; Tosyl Compounds; Transsexualism | 2000 |
Augmentation mammaplasty in male-to-female transsexuals.
Topics: Adult; Androgen Antagonists; Breast; Breast Implantation; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Male; Mammaplasty; Middle Aged; Mineralocorticoid Receptor Antagonists; Spironolactone; Transsexualism | 1999 |
Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Male; Middle Aged; Prostate-Specific Antigen; Time Factors; Tissue Kallikreins; Transsexualism | 2000 |
Relapse of hirsutism following long-term successful treatment with oestrogen-progestogen combination.
Topics: Adult; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans; Polycystic Ovary Syndrome; Recurrence; Retrospective Studies; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 2000 |
In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans.
Topics: Adolescent; Adult; Androgen Antagonists; CD4 Lymphocyte Count; Cyproterone Acetate; Cytokines; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Male; Middle Aged; Receptors, Chemokine; T-Lymphocytes, Helper-Inducer; Testosterone; Transsexualism | 2000 |
100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives.
Topics: Adult; Aspirin; Blood Viscosity; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Erythrocyte Aggregation; Erythrocyte Deformability; Ethinyl Estradiol; Female; Fibrinolytic Agents; Hemorheology; Humans; Norethindrone; Norethindrone Acetate; Norgestrel; Thrombophilia | 2000 |
Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome.
Topics: Acne Vulgaris; Adult; Case-Control Studies; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Ovary; Polycystic Ovary Syndrome; Time Factors; Ultrasonography | 2001 |
Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate.
Topics: Adult; Androgens; Blood Glucose; Case-Control Studies; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Secretion; Luteinizing Hormone; Polycystic Ovary Syndrome; Progesterone Congeners; Secretory Rate; Sex Hormone-Binding Globulin; Testosterone | 2001 |
Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.
Topics: Acanthosis Nigricans; Adolescent; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Diabetes Mellitus; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Hypertension; Insulin Resistance; Progesterone Congeners; Syndrome | 1997 |
Oral contraceptives in the treatment of acne.
Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Androgens; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Humans; United States | 2001 |
[Comparison of 2 therapeutic strategies for severe endometriosis, in young women counsulting for sterility or pain. Results in cases of chronic pelvic pain].
Topics: Adult; Cyproterone Acetate; Endometriosis; Ethinyl Estradiol; Female; Humans; Infertility, Female; Laparoscopy; Laser Coagulation; Middle Aged; Pelvic Pain; Pregnancy; Treatment Outcome | 2001 |
Diane 35 and spironolactone combination in the treatment of hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Spironolactone | 2001 |
[Cyproterone acetate].
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans | 2002 |
Estrogen and cyproterone acetate combination-induced autoimmune hepatitis.
Topics: Adolescent; Androgen Antagonists; Anti-Inflammatory Agents; Azathioprine; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Function Tests; Prednisolone | 2002 |
[A new ovulation inhibitor antiandrogen].
Topics: Acne Vulgaris; Alopecia; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Disease; Endocrine System; Ethinyl Estradiol; Family Planning Services; Hair Diseases; Hirsutism; Hormone Antagonists; Hormones; Physiology; Reproductive Control Agents; Signs and Symptoms; Skin; Therapeutics | 1984 |
[Influence of progestins on adverse effects of oral contraceptives].
Topics: Biology; Carbohydrates; Chemical Phenomena; Chemistry; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Disease; Endocrine System; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning Services; Glucose; Hormone Antagonists; Hormones; Levonorgestrel; Lipids; Lynestrenol; Metabolism; Norethindrone; Norethynodrel; Norgestrel; Organic Chemicals; Physiology; Reproductive Control Agents | 1985 |
[Treatment of acne with an antiandrogen containing contraceptive (Diane 35)].
Topics: Acne Vulgaris; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dermatitis; Disease; Endocrine System; Ethinyl Estradiol; Family Planning Services; Hormone Antagonists; Hormones; Physiology; Signs and Symptoms | 1988 |
[Clinical use of ethinyl estradiol in combination with cyproterone acetate. Study based on 50 cases (author's transl)].
Topics: Acne Vulgaris; Alopecia; Androgens; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dermatitis; Disease; Endocrine System; Ethinyl Estradiol; Family Planning Services; Hair Diseases; Hirsutism; Hormone Antagonists; Hormones; Physiology; Reproductive Control Agents; Research; Signs and Symptoms; Skin | 1982 |
Diane-35 (cyproterone acetate): safety concerns.
Topics: Androgen Antagonists; Canada; Consumer Product Safety; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk Factors; United Kingdom; Venous Thrombosis; Women's Health | 2003 |
Differences in the use of combined oral contraceptives amongst women with and without acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Prescriptions; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Polycystic Ovary Syndrome | 2003 |
The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Odds Ratio; Polycystic Ovary Syndrome; Risk Factors; Thromboembolism; Venous Thrombosis | 2003 |
Cluster-like headache time-locked to the menstrual cycle.
Topics: Acne Vulgaris; Adult; Cluster Headache; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Sumatriptan | 2003 |
Too much disclosure of product risks? CBC television, SOGC, and Diane-35.
Topics: Acne Vulgaris; Advertising; Androgen Antagonists; Canada; Cyproterone Acetate; Disclosure; Drug Combinations; Ethinyl Estradiol; Female; Humans; Odds Ratio; Risk Factors; United States; Venous Thrombosis | 2003 |
First-use risks.
Topics: Androgen Antagonists; Canada; Consumer Product Safety; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk Assessment; Risk Factors; Thromboembolism; Venous Thrombosis | 2003 |
Effect of two modes of antiandrogen treatment on insulin sensitivity and serum leptin in women with PCOS.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Apolipoproteins A; Apolipoproteins B; Blood Glucose; Body Composition; Body Constitution; Body Mass Index; Body Weight; C-Peptide; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Insulin; Insulin Resistance; Leptin; Lipoprotein(a); Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 2003 |
Prescribing pitfalls: cyproterone acetate with ethinyloestradiol.
Topics: Community Health Nursing; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Prescriptions; Ethinyl Estradiol; Humans; Medication Errors; Professional Autonomy; Writing | 2000 |
Absolute and attributable risk of venous thromboembolism in women on combined cyproterone acetate and ethinylestradiol.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Denmark; Epidemiologic Studies; Ethinyl Estradiol; Female; Humans; Risk Assessment; Risk Factors; Thromboembolism; Venous Thrombosis | 2003 |
[Assessment of efficacy of Diane-35 in androgenetic feminine alopecia].
Topics: Adult; Alopecia; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hair; Humans; Time Factors; Treatment Outcome | 2003 |
DISASTER operations of the Pennsylvania Department of Health in Hurricane Diane.
Topics: Cyclonic Storms; Cyproterone Acetate; Disasters; Drug Combinations; Ethinyl Estradiol; Humans; Pennsylvania | 1955 |
Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.
Topics: Activated Protein C Resistance; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hemostasis; Hormones; Humans; Male; Sex Characteristics; Testosterone; Transsexualism; Venous Thrombosis | 2003 |
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women with polycystic ovary syndrome: the effect of ethinyl estradiol-cyproterone acetate treatment.
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Melatonin; Polycystic Ovary Syndrome | 2003 |
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Melatonin; Polycystic Ovary Syndrome | 2004 |
Breast fibroadenoma in a male-to-female transsexual patient after hormonal treatment.
Topics: Adult; Androgen Antagonists; Breast Neoplasms, Male; Cyproterone Acetate; Ethinyl Estradiol; Fibroadenoma; Humans; Male; Transsexualism | 2003 |
Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
Topics: Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Risk Factors; Venous Thrombosis | 2004 |
Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Databases, Factual; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Polycystic Ovary Syndrome; United Kingdom; Venous Thrombosis | 2004 |
Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
Topics: Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Incidence; Italy; Risk Factors; Thromboembolism | 2004 |
Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.
Topics: Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Utilization; Ethinyl Estradiol; Humans; Middle Aged; Progestins; Pulmonary Embolism; Retrospective Studies; Venous Thrombosis | 2004 |
Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
Topics: Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Risk Factors; Safety; Venous Thrombosis | 2004 |
Cyproterone acetate and ethinylestradiol-induced pill oesophagitis: a case report.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Esophagitis; Esophagoscopy; Ethinyl Estradiol; Female; Hirsutism; Humans; Tablets; Ulcer | 2005 |
Simultaneous determination of cyproterone acetate and ethinylestradiol in tablets by derivative spectrophotometry.
Topics: Calibration; Cyproterone Acetate; Drug Stability; Ethinyl Estradiol; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tablets | 2005 |
Estrogen treatment effects on cognition, memory and mood in male-to-female transsexuals.
Topics: Adult; Affect; Cognition; Cyproterone Acetate; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Humans; Male; Medroxyprogesterone Acetate; Memory; Transsexualism | 2006 |
High performance liquid chromatography/ion-trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel.
Topics: Chromatography, High Pressure Liquid; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Levonorgestrel; Norpregnenes; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2007 |
[Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].
Topics: Androgen Antagonists; Blood Glucose; Body Composition; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Lipids; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome | 2006 |
Growth of a meningioma in a transsexual patient after estrogen-progestin therapy.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Estradiol; Ethinyl Estradiol; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Transsexualism | 2007 |
Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstruation Disturbances; Polycystic Ovary Syndrome; Practice Guidelines as Topic; Venous Thromboembolism | 2008 |
Disulfiram-like effect of cyproterone acetate.
Topics: Acetaldehyde; Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Disulfiram; Ethanol; Ethinyl Estradiol; Female; Flushing; Humans; Hypotension; Nausea; Syndrome | 2009 |
Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS).
Topics: Adult; Androgens; Arginine; Body Mass Index; Case-Control Studies; Contraceptives, Oral; Cyproterone Acetate; Ethinyl Estradiol; Female; Gonadotropins; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Time Factors | 2008 |
Assessment, diagnosis and treatment of a patient with hirsutism.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone; Ultrasonography | 2008 |
Homeostasis model assessment-insulin resistance (HOMA-IR), a key role for assessing the ovulation function in polycystic ovary syndrome (PCOS) patients with insulin resistance.
Topics: Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Models, Biological; Ovarian Follicle; Ovary; Ovulation; Polycystic Ovary Syndrome; Sensitivity and Specificity | 2008 |
[The effects of oxidative stress to PCOS].
Topics: Androgen Antagonists; Antioxidants; Ascorbic Acid; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipid Peroxides; Malondialdehyde; Oxidative Stress; Polycystic Ovary Syndrome; Superoxide Dismutase; Vitamin E | 2008 |
Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome.
Topics: Adult; Antigens; Carboxypeptidase B2; Cardiovascular Diseases; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Models, Biological; Polycystic Ovary Syndrome; Risk Factors; Thrombosis; Up-Regulation; Young Adult | 2008 |
Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexuals.
Topics: Adult; Amino Acids; Androgen Antagonists; Arginine; Cyproterone Acetate; Estradiol; Estrogens; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Male; Testosterone; Transsexualism | 2009 |
Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Topics: Acne Vulgaris; Adolescent; Adult; Age Factors; Alopecia; Androgens; Androstenedione; Body Mass Index; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Ethinyl Estradiol; Europe; Female; Follow-Up Studies; Hirsutism; Humans; Oligomenorrhea; Polycystic Ovary Syndrome; Risk Factors; Saliva; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography; Young Adult | 2009 |
[A case of Budd-Chiari syndrome induced by ethinylestradiol and cyproterone acetate].
Topics: Administration, Oral; Adult; Biomarkers; Budd-Chiari Syndrome; Cyproterone Acetate; Diagnosis, Differential; Ethinyl Estradiol; Female; Humans; Liver; Menstruation Disturbances; Radiography | 2009 |
Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.
Topics: Adult; C-Reactive Protein; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Follistatin; Humans; Obesity; Polycystic Ovary Syndrome; Prospective Studies | 2010 |
Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study.
Topics: Adolescent; Adult; Body Mass Index; C-Reactive Protein; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Homocysteine; Humans; Linear Models; Phenotype; Polycystic Ovary Syndrome; Prospective Studies; Statistics, Nonparametric | 2010 |
Simultaneous spectrophotometric determination of cyproterone acetate and ethinyl estradiol in tablets using continuous wavelet and derivative transform.
Topics: Analysis of Variance; Cyproterone Acetate; Ethinyl Estradiol; Linear Models; Reference Standards; Reproducibility of Results; Spectrophotometry; Tablets | 2010 |
Use of chemical mixtures to differentiate mechanisms of endocrine action in a small fish model.
Topics: Ammonia; Androgen Receptor Antagonists; Androgens; Animals; Benzhydryl Compounds; Carbanilides; Cyprinidae; Cyproterone Acetate; Endocrine Disruptors; Ethinyl Estradiol; Female; Male; Models, Biological; Phenols; Receptors, Estrogen; Water Pollutants, Chemical | 2010 |
Chronic urticaria and irregular menstrual cycle: a case report of effective therapy with oral contraception.
Topics: Adult; Androgen Antagonists; Chronic Disease; Contraceptives, Oral; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Ovarian Cysts; Urticaria; Young Adult | 2012 |
A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
Topics: Adolescent; Adult; Aged; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Follow-Up Studies; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Testosterone; Transsexualism; Young Adult | 2011 |
Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate/ethinylestradiol treatment for polycystic ovary syndrome: a case report.
Topics: Adult; Anticoagulants; Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Heparin, Low-Molecular-Weight; Heterozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Polycystic Ovary Syndrome; Thyroid Gland; Venous Thrombosis | 2011 |
Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome.
Topics: Adiposity; Adolescent; Adult; Androgen Antagonists; Body Fat Distribution; Carotid Intima-Media Thickness; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metabolic Syndrome; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2012 |
Co-cyprindiol prescribing in a large, rural general practice in England.
Topics: Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Drug Utilization; England; Ethinyl Estradiol; General Practice; Humans; Medical Records Systems, Computerized; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prescriptions; Rural Health Services | 2012 |
Improving the prognosis ways of central genesis and management option in infertile women.
Topics: Adolescent; Adult; Amenorrhea; Androgen Antagonists; Carbamazepine; Central Nervous System Diseases; Cinnarizine; Cyproterone Acetate; Desogestrel; Drug Combinations; Electroencephalography; Ethinyl Estradiol; Female; Humans; Infertility, Female; Oligomenorrhea; Progestins; Prognosis; Treatment Outcome; Young Adult | 2012 |
Scrutiny of Diane-35 due to potential dangers of off-label prescribing.
Topics: Canada; Cyproterone Acetate; Drug Combinations; Drug Labeling; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Ethinyl Estradiol; Female; Humans; Off-Label Use; Safety-Based Drug Withdrawals | 2013 |
[Pulmonary thromboembolism in primary care].
Topics: Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Primary Health Care; Pulmonary Embolism; Young Adult | 2013 |
[The hypocrisy of Diane®].
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans | 2013 |
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult | 2013 |
Clinical efficacy of low dose flutamide plus Diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Severity of Illness Index; Treatment Outcome; Women's Health; Young Adult | 2013 |
A case series of 11 patients with hormone-responsive sebaceous adenitis of the labia minora.
Topics: Adolescent; Adult; Androgen Antagonists; Anti-Bacterial Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Inflammation; Middle Aged; Sebaceous Gland Diseases; Spironolactone; Tetracyclines; Vulvar Diseases | 2014 |
Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2014 |
European Commission orders France to lift ban on acne pill.
Topics: Acne Vulgaris; Androgen Antagonists; Contraceptives, Oral; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Labeling; Ethinyl Estradiol; European Union; Female; France; Humans; Pulmonary Embolism; Safety-Based Drug Withdrawals; Thrombosis | 2013 |
[Oral contraceptives, risks and hazards].
Topics: Acne Vulgaris; Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; European Union; Female; France; Hirsutism; Humans; Risk Assessment; Safety-Based Drug Withdrawals | 2014 |
Cyproterone acetate-ethinyl estradiol use in a 23-year-old woman with stroke.
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Magnetic Resonance Imaging; Stroke; Tomography, X-Ray Computed; Young Adult | 2014 |
The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Androgen Antagonists; Aryldialkylphosphatase; Body Mass Index; Carboxylic Ester Hydrolases; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Metformin; Phospholipase A2 Inhibitors; Platelet Activating Factor; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Treatment Outcome | 2014 |
[Thrombosis and embolism during Diane-35 use: analysis of reports made to the Netherlands Pharmacovigilance Centre Lareb].
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Embolism; Ethinyl Estradiol; Female; Humans; Male; Netherlands; Pharmacovigilance; Risk Factors; Thrombosis | 2014 |
[Pill matters: targeted research into side effects necessary].
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Embolism; Ethinyl Estradiol; Female; Humans; Male; Pharmacovigilance; Thrombosis | 2014 |
Reflections after the Diane affair.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Cyproterone Acetate; Drug Combinations; Drug Industry; Ethinyl Estradiol; Female; France; Humans; Pharmacovigilance; Thrombosis | 2014 |
How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
Topics: Adolescent; Adult; Androgen Antagonists; Biomarkers; Blood Platelets; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Leukocyte Count; Mean Platelet Volume; Metformin; Polycystic Ovary Syndrome; Regression Analysis; Treatment Outcome | 2015 |
Environmental concentrations of anti-androgenic pharmaceuticals do not impact sexual disruption in fish alone or in combination with steroid oestrogens.
Topics: Androgen Antagonists; Anilides; Animals; Cyprinidae; Cyproterone Acetate; Disorders of Sex Development; Estradiol; Estrogens; Ethinyl Estradiol; Male; Nitriles; Oryzias; Rivers; Sewage; Sexual Development; Tosyl Compounds; Vitellogenins; Water Pollutants, Chemical | 2015 |
Polycystic ovary syndrome (PCOS): metformin.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Weight Reduction Programs | 2015 |
Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes.
Topics: Adolescent; Adult; Androgen Antagonists; China; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Metabolome; Metformin; Polycystic Ovary Syndrome; Treatment Outcome; Young Adult | 2015 |
Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
Topics: Abortion, Spontaneous; Adult; Androgen Antagonists; Blood Glucose; Body Mass Index; Clomiphene; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Live Birth; Luteinizing Hormone; Metformin; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Young Adult | 2015 |
Papillophlebitis associated with the use of oral contraceptive: a case report.
Topics: Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Ovarian Cysts; Papilledema; Young Adult | 2015 |
Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Outcome Assessment, Health Care; Polycystic Ovary Syndrome; Young Adult | 2016 |
[Changes of serum TOS and TAS levels and their association with apolipoprotein(a) in patients with polycystic ovary syndrome and infertility].
Topics: Antioxidants; Apoprotein(a); Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infertility, Female; Oxidative Stress; Polycystic Ovary Syndrome | 2016 |
Cost of Medications Recommended by Canadian Acne Clinical Practice Guidelines.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Androgen Antagonists; Androstenes; Anti-Bacterial Agents; Benzoyl Peroxide; Canada; Clindamycin; Cyproterone Acetate; Dermatologic Agents; Doxycycline; Drug Combinations; Estrogens; Ethinyl Estradiol; Humans; Isotretinoin; Mineralocorticoid Receptor Antagonists; Minocycline; Practice Guidelines as Topic; Severity of Illness Index; Tetracycline | 2016 |
Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Databases, Factual; Drug Combinations; Ethinyl Estradiol; Female; General Practice; Hirsutism; Humans; Hyperandrogenism; Off-Label Use; Polycystic Ovary Syndrome; Retrospective Studies; United Kingdom; Young Adult | 2017 |
Effects of antiandrogenic progestins, chlormadinone and cyproterone acetate, and the estrogen 17α-ethinylestradiol (EE2), and their mixtures: Transactivation with human and rainbowfish hormone receptors and transcriptional effects in zebrafish (Danio reri
Topics: Androgen Antagonists; Animals; Biomarkers; Chlormadinone Acetate; Cyproterone Acetate; Down-Regulation; Embryo, Nonmammalian; Endocrine Disruptors; Ethinyl Estradiol; Fishes; Humans; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Toxicity Tests; Water Pollutants, Chemical; Zebrafish | 2017 |
Concerning the Article by Fung et al, Titled "Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women".
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Prolactin; Spironolactone; Transgender Persons | 2017 |
Response to "Letter to the Editor Concerning the Paper by Fung et al titled 'Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women".
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Prolactin; Spironolactone; Transgender Persons | 2017 |
Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin.
Topics: Adult; Amidohydrolases; Androgen Antagonists; Arachidonic Acids; Cyproterone Acetate; Drug Combinations; Endocannabinoids; Endometrium; Ethinyl Estradiol; Female; Glycerides; Humans; Infertility, Female; Metformin; Polycystic Ovary Syndrome; Polyunsaturated Alkamides; Receptors, Cannabinoid; Young Adult | 2017 |
Prescription Appropriateness of Cyproterone Acetate/Ethinylestradiol in Primary Care: A Population-Based Study in Italy.
Topics: Acne Vulgaris; Adolescent; Adult; Cyproterone Acetate; Drug Combinations; Drug Utilization; Ethinyl Estradiol; Female; Humans; Middle Aged; Primary Health Care; Young Adult | 2017 |
Treatment of hyperandrogenism in women with ethinylestradiol and cyproteroneacetate.
Topics: Androgen Antagonists; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome | 2017 |
Thrombotic risk minimization for Diane-35 and generics.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Androgen Antagonists; Cohort Studies; Cyproterone Acetate; Databases, Factual; Drug Combinations; Drug Utilization; Drugs, Generic; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Menstruation Disturbances; Middle Aged; Netherlands; Retrospective Studies; Risk Reduction Behavior; Thrombosis; Young Adult | 2017 |
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Breast Neoplasms; Contraceptive Agents; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Incidence; Medical History Taking; Middle Aged; Norpregnenes; Retrospective Studies; Risk Factors; Young Adult | 2018 |
Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
Topics: Adult; Anti-Obesity Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Young Adult | 2018 |
Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.
Topics: Adult; Androgen Antagonists; Birth Weight; China; Clomiphene; Cyproterone Acetate; Diabetes, Gestational; Drug Combinations; Ethinyl Estradiol; Female; Fertility Agents, Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Complications; Premature Birth; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Time-to-Pregnancy; Treatment Outcome; Young Adult | 2018 |
Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene's paraurethral glands) of adult gerbils (Meriones unguiculatus).
Topics: Animal Structures; Animals; Contraceptives, Oral, Combined; Cyproterone Acetate; DNA Modification Methylases; Drug Combinations; Estrogen Receptor alpha; Ethinyl Estradiol; Female; Genitalia, Female; Gerbillinae; Immunohistochemistry; Male; Microscopy, Electron, Transmission; Proliferating Cell Nuclear Antigen; Prostate; Receptors, Androgen; Up-Regulation; Urethra; Vagina | 2018 |
Identification of molt-inhibiting hormone and ecdysteroid receptor cDNA sequences in Gammarus pulex, and variations after endocrine disruptor exposures.
Topics: Amino Acid Sequence; Androgens; Animals; Brachyura; Cyproterone Acetate; DNA, Complementary; Ecdysteroids; Endocrine Disruptors; Environmental Biomarkers; Environmental Exposure; Environmental Monitoring; Estrogen Antagonists; Estrogens; Ethinyl Estradiol; Invertebrate Hormones; Life Cycle Stages; Methyltestosterone; Molting; Polymerase Chain Reaction; Receptors, Steroid; Risk Assessment; Tamoxifen | 2018 |
Association between CD16
Topics: Adult; Biomarkers; Case-Control Studies; China; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Insulin Resistance; Metformin; Monocytes; Polycystic Ovary Syndrome; Prospective Studies; Receptors, IgG | 2019 |
Electrochemical study and simultaneous voltammetric determination of contraceptives ethinylestradiol and cyproterone acetate using silver nanoparticles solid amalgam electrode and cationic surfactant.
Topics: Cations; Cetrimonium; Cyproterone Acetate; Drug Compounding; Electrochemical Techniques; Electrodes; Ethinyl Estradiol; Humans; Metal Nanoparticles; Molecular Conformation; Silver; Surface-Active Agents | 2020 |
Reduction in use of cyproterone/ethinylestradiol (Diane-35 and generics) after risk minimization measures in the Netherlands, UK and Italy.
Topics: Acne Vulgaris; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Humans; Italy; Netherlands; Retrospective Studies; United Kingdom | 2020 |
Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
Topics: Androgen Antagonists; Animals; Apoptosis; Body Weight; Cyproterone Acetate; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Glycolysis; Hypoglycemic Agents; Insulin Resistance; Lactate Dehydrogenase 5; Luteinizing Hormone; Metformin; Ovary; Ovulation; Polycystic Ovary Syndrome; Pyruvate Kinase; Rats; Sirtuin 1; Testosterone | 2020 |
Diane-35 and Metformin Induce Autophagy and Apoptosis in Polycystic Ovary Syndrome Women with Early-Stage Endometrial Carcinoma.
Topics: Androgen Antagonists; Animals; Apoptosis; Autophagy; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Endometrial Neoplasms; Ethinyl Estradiol; Female; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin-Like Growth Factor I; Metformin; Mice; Polycystic Ovary Syndrome; Receptors, Androgen | 2022 |
Metabolic and Dietary Factors in Acne Vulgaris and Evaluation of the Acne Vulgaris Treatment with Oral Contraceptive-Based Therapies in Young Adult Women.
Topics: Acne Vulgaris; Contraceptives, Oral; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Young Adult | 2023 |